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A DISTINCT PATTERN OF STERILE INFLAMMATION INDUCED BY ZINC 
OXIDE NANOWIRES 
Ruqaih Salem Alghsham 
August 2, 2019 
In recent years, there has been an increasing interest in nanotechnology. 
Engineered nanomaterials (ENMs) become an increasingly important area in 
nanotechnology. Recent developments in ENMs have drawn commercial and 
research attention in many areas such as agriculture, medicine, and Industry. 
High-aspect ratio zinc oxide nanowires (ZnONWs) have become one of the most 
significant ENMs due to their remarkable physical properties which makes them 
useful in a wide-range of applications. However, questions have been raised 
about ZnONW safety uses and biological consequences. 
In this dissertation, we investigated the inflammatory potential of ZnONWs 
in mouse models. C57BL/6 mice were exposed to ZnONW via intra-tracheal 
route. Two days post-instillation, the broncho-alveolar lavage fluid (BALF) was 
analyzed for inflammatory cells and for presence of pro-inflammatory cytokines. 
viii 
We found that the intratracheal instillation of ZnONW in C57BL/6 mice induced a 
significant increase in the total numbers of immune cells in BALFs two days after 
instillation. Macrophages and eosinophils were the predominant cellular infiltrates 
of ZnONW-exposed mouse lungs. In an air-pouch mouse model that simulates 
local exposure to ZnONW, similar cellular infiltrates were observed. Analysis of 
lavage fluids revealed that pro-inflammatory cytokines IL-6 and TNF-α as well as 
chemokines CCL11 and CCL2 were increased both in BALFs and air-pouch 
lavage fluids. The cellular basis of inflammatory mediators that were induced by 
ZnONW were investigated in cultured cells. ZnONW exposure induced both IL-6 
and TNF-α production only in macrophages but not in lung epithelial cells 
(LKR13). Exposure of macrophages to ZnONW induced the production of CCL11 
only while LKR13 cells induced both CCL11 and CCL2. Confocal microscopy 
showed rapid phagocytic uptake of FITC-ZnONW aggregates by macrophages. 
The phagocytosis of ZnONW particles is essential for the production of both IL-6 
and TNF-α.  These results suggest that exposure to ZnONW may induce distinct 
inflammatory mediators through phagocytic uptake. 
ix 
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Engineered nanomaterials (ENMs) 
Material with a one or more dimensional shape in the size range from 1 to 100 
nanometers (nm) are referred to as nanomaterials [1, 2]. There are two types of 
nanomaterials: naturally occurring nanoparticles, which are also referred to as 
ultrafine nanoparticles, and engineered nanoparticles (ENPs). The naturally 
occurring nanoparticles include volcanic ash soot from forest fires or diesel 
engines [3-6]. These naturally occurring nanomaterials are usually physically and 
chemically heterogeneous [7]. On the other hand, engineered nano-materials 
(ENMs) are created by the manipulation of matter at the nano-scale to produce new 
materials and structures [8, 9]. A myriad of new ENMs are being rapidly developed and 
introduced into many different sectors, such as commerce, agriculture, and medicine [10-
12]. 
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ENMs are designed with very specific properties related to chemistry, 
shape, size, and surface area. Their novel physicochemical properties facilitate 
wide-range of applications in consumer products, such as food additives, 
batteries, cosmetics, drug delivery system, and sunscreens [12].  ENMs are 
being produced in large-scale quantities, thereby posing unknown environmental, 
human, and occupational exposure hazards. The tiny size and light weight of 
these ENMs make control, such as filtration or dampening, difficult. 
Types of engineered nanomaterials 
There are different types of ENMs exist; however, for the purpose of this 
dissertation, the focus is on two types of ENMs: metal-based ENMs and carbon-
based ENMs. Metal-based ENMs are defined by particles that are made of metal 
precursors while carbon-based ENMs contain predominantly carbon atoms that 
are arranged in a unique way. 
Commonly used ENMs 
 Metal-based ENMs
 Silicon dioxide nanoparticles (SiONP): SiONP is the main component
for the manufacturing of several consumer products, such as glass, 
paints, plastics, cosmetics, food additives, and rubber [13, 14]. 
 Titanium oxide nanoparticles (TiONP): TiONP has applications in the
manufacturing of cosmetics, food, and sunscreen products. The unique 
properties and the size of TiONPs allow them to form a protective layer 
on the skin without being completely absorbed [13]. 
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 Zinc oxide nanoparticles (ZnONP): With the significant advancement
in the alternative energy market, ZnONP has become one of the 
leading metal oxide ENMs used in electronics, optical devices. ZnONP 
is also used in battery storage due to its photocatalytic activity [15]. 
 Aluminum oxide nanoparticles (AlONP): AlONP is commonly used in
making cement, paints, and aircrafts. 
 Carbon-based ENMs
 Graphene: Graphene is a nanomaterial composed of an allotropic, two-
dimensional hexagonal structure of carbon atoms, which was first 
described in the 1970s; however, nano-scale graphene was introduced 
in 2004 with different structures, such as single layers, nanotubes, and 
fibers. Recently, graphene has become a promising nanomaterial for 
many bio-technological applications, in the field of environmental 
engineering and biomedicine [16]. 
 Single or multi-walled carbon nanotubes (CNTs): CNTs are derived
from graphene, which is considered one of the oldest and most widely 
used natural nanomaterial. CNTs are used in many applications, such 
as biomedical and electronic devices [17, 18]. 
ENMs market dynamics 
In 2015, the global market for nanotechnology was predicted to grow and 
to employ up to two million workers [19]. By 2022, the anticipated benefits from 
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the ENMs market will be $55 Billion (Fig1) [20]. The US and Japan have over a 
half of the world’s demand for ENMs. The U.S. leads the global market and the 
recent developments in the field of ENMs by 46%, especially in the global health 
sector [20]. Hence, in the U.S. alone, 800,000 workers face a high probability for 
occupational exposure hazards to ENMs [21]. According to Nanowerk, there are 
more than 1,000 consumer products containing ENMs. Approximately 2,500 
commercial ENMs are used, that including 27% metal oxide nanoparticles, such 
as ZnONP and SiONP [.http://www.nanowerk.com/ phpscripts/ndbsearch.php]. 
The growing production of ENMs has raised concerns related to their potential 
effects on the environment and biological health. In addition, ENMs are 
synthesized in and with varying shapes, sizes, coatings, surface charges, and 
surface areas, which makes both biological and environmental potential hazards 
unpredictable. Hence, the biological and environmental impacts of ENMs must 
be determined. 
Dynamics of the global nanomaterials demand by regions bases is 
listed below from the highest to the lower demand 
• North America includes the U.S., Canada, and Mexico.
• Europe includes the UK, Germany, France, and Italy.
• The Asian Pacific region includes China, India, and Japan.
• Central and South America (Brazil).
• The Middle East includes Saudi Arabia and Turkey.
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Figure 1: The ENMs market growth from the base year 2010 to 2022 in 
terms of revenue (USD billion) [20].  
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The environmental and biological impacts of ENMs 
In the past two decades, nano-toxicology has become a highly important 
field in science due to an increase in the utilization of ENMs. This has increased 
the need for studying the potential side effects of ENMs in biological and 
ecological systems, which will ultimately contribute to understanding and 
generating rules and safety measurements when using and synthesizing ENMs. 
In this section, the implications of ENMs for environmental and biological 
systems are discussed. 
The environmental impacts 
     Without doubt, the volume of ENMs released into the environment will 
increase due to the widespread use of products containing ENMs either during 
manufacture, transport, use, or disposal [22]. Consequently, the entire 
environmental compartment will be affected. The eco-toxicological effects of 
ENMs are not well-defined and require further investigation [23] for several 
reasons. First, the current data on the actual volume release of ENMs and the 
accumulated concentration into the environment are poorly understood and 
limited [24-26]. This is because the lack of data on the production volumes of 
ENMs creates a fundamental obstacle to future investigations into their release 
[27, 28]. Another challenge is that different ENMs accumulate at different sizes 
and rates in the environment depending on the variable abiotic factors in the 
environment (pH soil, ionic composition, and soil texture), which leads to 
differences in eco-toxicological outcomes. Furthermore, there is a lack of suitable 
tools, analytical approaches, and methods to study the environmental impact of 
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ENMs. Another important question that needs to be addressed is what is the fate 
of the end-of-life product of ENMs and their proper safe disposal methods? 
Therefore, there is a compelling need to study and to investigate the actual 
release and distributions of ENMs in the environment to better understand their 
impacts [29-32]. Previous studies have shown that soluble metal oxide ENMs, 
such as TiO2 and ZnO, might accumulate in environmental components (soils, 
soil’s organisms, and freshwater) as particulates in concentrations that exceed 
the sub-toxic levels [27, 33-35]. Furthermore, some metal oxide materials, such 
as TiO2 and ZnO, which are essential elements in many consumer products, 
have antimicrobial properties that may pose a direct or indirect impact, triggering 
alterations in the ecosystem, including fish, bacteria, and plants [36]. Table 1 
presents the environmental concentrations of some ENMs in three main 
pathways into the environment. 
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Table 1: Predicted environmental concentrations of highly used ENMs in three 
main pathways into the environment (modified and reproduced from Ref [37]). 
ENMs Surface water WWTP Sludge WWTP Waste and 
Sewage 
ZnONP 1−10 000 ng/L 13.6−64.7 mg/kg, 0.22−1.42 μg/L, 
TiONP 21−10 000 ng/L 100−2000 mg/kg 1−100 μg/L 
CNP 0.001−0.8 ng/L 0.0093−0.147 
mg/kg 
3.69−32.66 ng/L 
AgNP 0.088−10 000 ng/L 1.29−39 mg/kg 0.0164−17 μg/L 
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The biological impacts 
     The potential consequences of ENMs on biological systems strongly 
depend on the physical and chemical properties as well as the route of exposure 
[38]. Several studies have reported the toxicity of ENMs in both in vitro and in 
vivo experimental models [39-52]; however, the biological effects of many of the 
ENMs are not well-defined. The small sizes of ENMs allow them to infiltrate 
epithelial barriers, causing their accumulation and deposition into vital organs 
and tissues, including the kidneys, heart, and liver [53-57]. In addition, some 
forms of ENMs may cross blood-brain barriers, leading to brain damage and 
neurological side effects [55]. Furthermore, studies have shown that exposure to 
ENMs via several routes, such as inhalation, ingestion, or dermal contact, could 
lead to a variety of disorders, such as myocardial infarction, stroke, thrombosis 
caused by platelet enhanced aggregation by ENMs [58-60], and lung injury or 
inflammation [61, 62]. Moreover, at the cellular level, ENMs may induce cell 
death, mitochondrial damages, and genotoxicity (DNA damage and mutation) 
[53, 63, 64]. The leakage of ENMs ions from their core may elicit biological 
consequences, especially if the metal ion released has biological and 
physiological functions. Earlier studies have suggested that the production of 
reactive oxygen species (ROS) and free radicals are the underlying mechanisms 
of ENMs cytotoxicity. Cell death and cell damage could result from ROS or 
ENMs’ physical damage of cell membranes. In addition to oxidative stress, 
inflammation, DNA damage, and apoptosis have also been suggested to be 




ENMs induce toxicity have been suggested, such as the disruption of intracellular 
transport and cell division, a disturbance in DNA transcription, mitochondrial 
damage and dysfunction, and lysosomal destabilization, leading to autophagy 
and cell death [72].  Moreover, genotoxicity is one of the biological side effects of 
ENMs exposure, and ENMs genotoxicity is defined by the damage of the 
intracellular DNA that could result from direct ENM interactions with DNA or 
indirect interactions via ROS production after ENM exposure; however, long-term 
secondary adverse effects, such as chronic respiratory distress syndrome, of 
ENMs are overlooked and require further investigation. 
OSHA’s exposure limit recommendations 
• Respirable carbon nanotubes and carbon nanofibers should not exceed 
1.0 (μg/m3) as an eight-hour time-weighted average (TWA). 
• TiONPs (particle size less than 100 nm) should not exceed 0.3 (mg/m3). 
• TiONPs (particle size greater than 100 nm) should be 2.4 mg/m3.  
OSHA’s permissible exposure limits to zinc oxide fumes 
•  5 mg/m3 (TWA). 
• 10 mg/m3 short-term exposure limit (STEL).  




Figure 2: The schematic model illustrates the mechanisms in which ENM 
induces cytotoxicity: ENMs induce ROS generation, which leads to oxidative 
stress. Oxidative stress could either be induced cell death or DNA damage that 
could lead to an inflammatory response. ENMs could also prompt inflammation 








Factors influence ENMs toxicity 
The physicochemical properties of ENMs, including dissolution, size, 
shape, chemical composition, surface area, and charge, influence the biological-
interaction of ENMs. Thus, for a complete understanding of the biological impacts 
of ENMs, it is important to evaluate the physicochemical properties of ENMs and 
to understand the interaction between these properties to determine the toxic 
potential of ENMs in the biological system. There are underlying factors that 
contribute to ENMs toxicity: size, shape, surface area, charge, and chemical 
composition. 
Size 
Size is an important factor that determines the effective interaction 
mechanism between ENMs and biological systems, especially the immune 
system. It has been suggested that the smaller the particles, the more 
toxic they are [73]. ENMs with a size less than 20 nm can easily traverse 
through epithelium and endothelium barriers and enter cells. The small 
size of ENMs, which is similar to the size of spheroproteins (2-10 nm), not 
only enable their translocation through cellular membranes but also allows 
them to enter the nuclei and other cell organelles [74]. According to Huo et 
al., six nm gold NPs were found in the nucleus, while 16 nm gold NPs 
were only found in the cytoplasm [75]. Furthermore, size controls the 
recognition, uptake, and clearance of ENMs by immune cells, such as 
macrophages. ENMs with a size less than five nm enter the cell 
membrane via nonspecific transport mechanisms, whereas 10 to 25 nm 
13 
ENMs are taken up by immune cells through pinocytosis. Larger particles 
are believed to be prime for the phagocytosis mechanisms, such as 
micropinocytosis [76, 77]. Due to the small size, ENMs of 5-10 nm will be 
not cleared effectively by immune cells, which leads to the accumulation 
and translocation of ENMs in vital organs [78-80]. Aggregation and 
agglomeration also contribute to the size and toxicity of ENMs. Once 
ENMs interact with biological media, they can aggregate or agglomerate1, 
which can influence the particle size and can lead to different biological 
effects. 
Shape 
ENMs have different shapes, such as spheres, sheets, cubes, rods, 
and ellipsoids. The shape as well as the aspect ratio are the two essential 
elements that influence the toxicity of ENMs. Several studies have 
investigated shape-dependent toxicity [81-84]. According to Holian et al., 
the clearance of TiONPs, either spherical or nano-belts, was affected by 
particle shape after pulmonary lung exposure in mice. TiONP spheres 
were cleared more effectively than TiONP nano-belts [85]. Moreover, rod-
like or needle-like ENMs induced more cell death and damage compared 
to spherical ENMs [86]. Overall, shape controls the uptake and clearance 
of ENMs by phagocytes and could lead to cell death and damage. 
_____________________________________________________________________________ 
1Aggregation is different from agglomeration: aggregation cannot be reversible under any certain 
conditions, while in agglomeration, under some chemical/biological conditions, the release of the 
actual primary individual particles is possible [21]. 
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Surface area and charge 
      ENMs are characterized by a large surface area, which provide them 
with a high reaction capacity and a high catalytic activity compared to 
micro-particle of the same material. Because the first interactions between 
ENMs and biological systems begin at the surface of the ENMs, the 
surface area plays a role in toxicity. The smaller the size, the more surface 
area they have and the higher toxicity [73]. The surface charge 
significantly contributes to the toxicity of ENMs [87, 88]. Surface charges 
affects the interaction and translocation of ENMs. Positively charged 
ENMs were found to be more toxic than negative or neutral ENMs [89]. 
The electrostatic attraction between the negative charges of the cell 
membrane (glycoprotein) and the positive charge of ENMs allows them to 
enter the cell easily compared to neutral or negatively charged ENMs [90]. 
Moreover, positively charged ENMs adsorb protein more efficiently than 
those with a negative charge. The adsorption with serum protein and other 
proteins allows ENMs to form a protein corona. This formation has a direct 
effect on the uptake and recognition of ENMs by immune cells [91]. 
Chemical composition 
  Particle chemistry is a crucial aspect of cell molecular mechanisms 
and oxidative stress. The chemical stability of ENMs is affected by the 
environmental conditions inside the cells, e.g., the pH level. Therefore, 
chemical composition is another factor that affects ENMs toxicity. Some 
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ENMs, such as ZnONP, is known to have a high dissolution rate with a low 
pH [92]. Although Zn and other metal ions have biological benefits for the 
cell, studies have shown that ZnONP induces toxicity and cell death due 
to the dissolution of ZnONP inside the acidic vacuoles of cells, leading to 
an increase in the Zn ions inside the cells [92]. The type of metal also 
contributes to the toxicity and has different toxic effects. A comparison 
study was performed to study the toxicity effect of SiONPs and ZnONP. 
SiONP induce toxicity by altering the DNA structure of the cells, whereas 
toxicity induced by ZnONP is caused by the production of ROS and 
oxidative stress [93], indicating that particle chemical composition played a 
primary role in the cytotoxic function. 
In summary, shape, size, chemical composition, surface charge, and area 
are major factors that determine and influence the toxicity of ENMs; however, 
other factors must be investigated, such as coating and surface roughness. 
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Sterile inflammation 
 The immune system plays a vital role in host defense against intrusion, 
including by pathogens, through the process of inflammation. For microbial 
infections, an inflammatory cascade promotes the recruitment and activation of 
innate immune cells, such as macrophages and neutrophils [94]. These cells 
have a role-clearing microbe though phagocytosis and the production of pro-
inflammatory cytokines and chemokines to activate an adaptive immune 
response. Inflammation can also be triggered in response to non-microbial 
agents. This type of inflammation is known as sterile inflammation, which is an 
inflammation triggered by pathogen-free agents, such as physical, chemical, or 
metabolic insults, including environmental particles, such as asbestos and silicon 
dioxide crystals [94, 95]. Sterile inflammation is considered one of the underlying 
factors that lead to many inflammatory diseases. ENMs, such as metal-oxide and 
carbon-based nanoparticles, may initiate sterile inflammation [96]. Similar to 
pathogen-induced inflammation, ENMs may prompt sterile inflammation and may 
induce the recruitment of inflammatory cells, such as macrophages and 
neutrophils, and the production of pro-inflammatory cytokines because they can 
function as danger signals (DAMP) [96]. The inflammation cascade may be 
induced by damage-associated molecular patterns (DAMP) [97]; Previous 
studies reported that ENMs promote the secretion of chromatin associates 
protein high-mobility group box-1 (HMGB-1) which considered as highly active 
danger signal that initiate inflammatory cascade [98]. However, the process of 
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inflammation induced by ENMs is not fully understood, and the possible 
biological consequences of ENMs-induced sterile inflammation requires further 
investigation [96]. Table 2 provides a list of in vitro studies that investigated the 
signaling pathway of sterile nanoparticles-induced sterile inflammation.  [96, 99-
103]. 
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Table 2: In vitro studies that investigated the signaling pathway of sterile nano-
particles induced inflammation.  
Type of 
nanomaterial 
Cell type Signaling pathways Biological effect 





Activation of the 
inflammasome 
–caspase-1 related
pathway leading to 
IL- 
β and IL-18 
release 


















The activation of 
NLRP-3 complex 
causes the release 
of functionally 
active IL-1β. 















cleavage and IL-1β 
secretion via the 
NLRP-3 
inflammasome 






Activation of the 
inflammasome –
caspase-1 related 
pathway leading to 
IL-β and IL-18 
release. 
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Zinc oxide nanoparticle (ZnONP) 
   ZnONP applications 
Zinc oxide nanoparticles (ZnONP) have become one of the most important 
and promising metal oxide nanoparticles that are commonly used in many 
different areas due to their unique physical and chemical properties [104, 105]. 
ZnONP have been used in many industrial products. In 2015, worldwide 
production was estimated to be about one million tons per year. The rubber 
industry was the first known to use ZnONP based on their waterproof function 
and enhancement of the performance of high polymers in rubber [106, 107]. 
Later, due to ZnONP’ UV absorption properties, they were used in many 
personal consumer products, such as cosmetics and sunscreen [108]. Moreover, 
ZnO has an antimicrobial activity, and thus ZnONP is commonly used as food 
additives as well as in the textile industry and for deodorants and antibacterial 
products [109]. ZnONP has a promising application in the field of electro, opto, 
and photo technology, electronic/electrical devices, and batteries [110-112]. 
Apart from these applications, ZnONP have attracted considerable attention in 
the medical field and are used in drug delivery systems and anticancer 
treatments, and they have the potential to enhance other drugs’ activities, such 
as insulin [110, 113, 114]. The tremendous increase in production and the use of 
ZnONP poses a large risk of exposure to both the public and workers, who could 
be exposed through different routes, such as ingestion, inhalation, or skin contact 
[21]; however, the biological effect of ZnONP remains controversial in recent 
studies. Previous studies have shown that ZnONP has anti-inflammatory 
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properties due to the suppression of the mRNA expression of many inflammatory 
cytokines, such as IL-1β and TNF-α [115-121]. Moreover, the U.S. Food and 
Drug Administration (FDA) categorized the use of ZnO in micron sizes as safe, 
“GRAS” (generally recognized as safe), for use as food additives but not ZnONP. 
On the other hand, many other studies have suggested that ZnONP indeed 
exhibit inflammatory potential both in vivo and in vitro. 
  Potential exposure hazards and side effects of ZnONP 
It has been known for some time that metal fume fever syndrome is 
caused by the inhalation of ZnO fumes among foundry workers [122-125]. 
Exposure to ZnONP may also lead to health complication. Consequently, there is 
a need for an evaluation of the health consequences of ZnONP exposure. 
ZnONP could be recognized by the immune system as danger signals. 
Consequently, inflammatory responses to ZnONP could lead to a wide range of 
disorders. Several studies have demonstrated that ZnONP have the ability to 
induce toxicity both in vivo and in vitro. 
 In vitro toxicity of ZnONP 
Extensive studies have investigated the toxicity effect of ZnONP in 
different cell lines. 
Production of reactive oxygen species (ROS) 
ROS is formed as a result of mitochondrial oxidative metabolism 
and cellular responses to bacterial infections. It is composed of different 
oxidative species, which include superoxide anion, hydrogen peroxide, 
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singlet oxygen, and hydroxyl radicals. ROS is known for its regulatory role 
in cell signaling and homeostasis [126]. There are two types of sources 
that induce ROS formation within the cells: endogenous and exogenous. 
Mitochondrial respiration and inflammatory responses are some of 
endogenous sources for ROS generation, while bacterial invasion, 
pollution, and ENMs act as exogenous sources. Several studies have 
shown that ZnONP induce a substantial increase in the ROS level in vitro 
after ZnONP exposure [127-131]. Thus, ROS production leads to oxidative 
stress and mitochondrial damage [132]. 
Oxidative stress 
Upon ZnONP exposure, the intracellular levels of ROS increases. 
This triggers the enzymatic and non-enzymatic antioxidant system in cells. 
When the antioxidant system in the cell is exhausted, the cells fail to 
reduce the intracellular ROS level, leading to ROS accumulation and a 
disturbance in the cellular homeostasis. As a result, oxidative stress 
occurs. Oxidative stress contributes to cell damage, mitochondrial 
damage, and autophagy [132-137]. 
Another cellular response to ZnONP is the production of pro-
inflammatory cytokines. The interaction of ENMs with cell surface 
receptors leads to the activation of intracellular signaling pathways. 
According to Roy et al., Toll-like receptor 6 (TLR6) mediates the 
inflammatory responses of ZnONP in peritoneal macrophages [138]. The 




mediated through the activation and upregulation of inflammatory 
pathways, including nuclear factor kappa-light-chain enhancer of activated 
Bcells (NF-κβ), mitogen-activated protein kinase (MAPK), and other 
pathways involved in Myeloid differentiation primary response 88 (myD88) 
[139-141]. 
Genotoxicity 
Genotoxicity is a potential biological response to ZnONP exposure.  
It has been shown that high doses of ZnONP leads to cellular toxicity and 
cell death; however, the effect of a low dose of ZnONP exposure has been 
overlooked. Low doses of ZnONP could lead to genetic alterations, 
causing DNA damage [142-145]. According to Heim et al., ZnONP 
induces a DNA double strand break [146]. These genetic alterations could 
lead to mutations and carcinogenesis. The genotoxicity of ZnONP was 
investigated in kidney epithelial cells and other cell types [147]. ZnONP 
induces DNA damage due to an increase in ROS generation, which 
results from an increase in intracellular Zn2+ ion concentrations. ZnONP 
also induces dysregulation in cardiac functions and vascular homeostasis. 
Intra-tracheal instillation of ZnONP to Wistar rats induced systemic 
inflammation, dyslipidemia, increase levels of serum biomarkers of 
atherosclerogenesis (heme oxygenase-1 [HO-1] and platelet endothelial 
cell adhesion molecules-1 ,and aortic pathological damage [148].  
The underlying factor that leads to ZnONP toxicity is the solubility of 
ZnONP in the acidic vacuole of the cells, such as phagolysosome. This leads to 
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an increase in the intracellular Zn2+ ions concentration [149-152]. The Zn2+ ion is 
an essential element in many biological reactions. It is important for enzyme 
activity and many nuclear proteins, such as zinc finger nucleases [113]. 
   In vivo ZnONP toxicity 
Several studies have investigated the toxicological effect of ZnONP in vivo 
[153-156]. The intra-tracheal instillation of ZnONP in mice induced acute lung 
inflammation and lung injury with a significant increase in the LDH level detected 
in bronchial alveolar lavage fluids (BALF) [157, 158]. Moreover, ZnONP induced 
the recruitment of macrophages and neutrophils with high levels of pro-
inflammatory cytokines, such as IL-6 in BALF, after pulmonary exposure in mice 
[159-161]. Furthermore, ZnONP appears to have an adjuvant-like response to 
allergen ovalbumin (OVA) and induce Th2 responses in mice [154]. Oral 
exposure to ZnONP in rats for five days revealed significant hepatic damage and 
severe nephrotoxicity [162, 163]. According to Attia et al., neurotoxicity in rats 
was observed after oral exposure to ZnONP resulting in oxidative stress and 
genotoxicity, inflammation, and apoptosis [133]. In addition, a study conducted 
with human volunteers showed that the inhalation of ZnONP induces flu-like 
symptoms and a significant increase in serum amyloid A (SAA), and two acute 
phase proteins C-reactive protein (CRP) [164]. It has been suggested that the 
toxicity of ZnONP in vivo is similar to the in vitro finding of the solubility of ZnONP 
in the acidic pH of cell vacuoles [165]; however, a study conducted by Xia et al. 
showed that dietary ZnONP improved intestinal microbiota and inflammation 
responses in weaned piglets [166]. 
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ZnONP and the innate immune cells 
The innate immune system (nonspecific) is the first line of defense against 
foreign insults, including ENMs. The interaction of ENMs with innate immune 
cells may induce an immunomodulatory response either by the activation or the 
suppression of the innate immune system (Fig3) [98, 167]. The key mechanism 
of the innate immune system is the process of phagocytosis. Phagocytic cells, 
such as macrophages, and other phagocyte cells mediate the phagocytosis 
process through pattern recognition receptors (PRPs) on phagocytic cells, (e.g. 
toll-like receptors (TLR)), that recognize a wide variety of pathogens’ molecular 
patterns referred to as pathogen-associated molecular patterns (PAMPs) such as 
lipopolysaccharides (LPS) on the bacterial cell wall [168]. Similarly, macrophages 
could recognize ENMs. ENMs may interfere with  It has been suggested that 
ENMs may serve as DAMP signals that could induce innate immune reactions 
[96].Several studies have shown that ZnONP induces the activation and 
recruitment of innate immune cells upon exposure either in vitro or in vivo 
correspondingly. 
Macrophages and ZnONP 
     Macrophages are the first responders to danger signals. They are 
professional phagocytic cells that mediate recognition and phagocytosis via 
different reporters, including scavenger receptors (SR), mannose receptors (MR), 
and complement receptors (CR) [169]. Furthermore, receptors on macrophage 
such as TLRs play a vital role in the early recognition of ZnONP and 
subsequently induce a pro-inflammatory response [141, 170]. According to Roy 
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et al., the inflammatory responses of activated macrophages triggered by ZnONP 
depend on TLR6, which induces the expression of genes involved in 
inflammation. Briefly, ZnONP promoted the expression of CD1d, MHC-II, CD86, 
and CD71, which are activation and maturation markers, on macrophages as 
well as the production of pro-inflammatory cytokines, such as IL-6, IL-1β, and 
TNF-α. The production of these pro-inflammatory cytokines was suppressed after 
inhibiting MAPKs pathways and TLR6 signaling using siRNA [138]. Moreover, the 
downstream signaling of TLRs mediates the activation of many inflammatory 
pathways, such as MAPK, ERK1/2, JNK, p38, and NF-κB. The activation of these 
pathways leads to the production of pro-inflammatory cytokines and chemokines 
by the recruitment of a specific set of adaptor molecules, such as MyD88 and 
TRIF [171]. It has been suggested that ZnONP induces inflammatory responses 
through the activation of MyD88, NF-κB, and MAPK [139]. Furthermore, the 
activation of TLR signaling not only induces inflammation and the production of 
pro-inflammatory cytokines but also increases the phagocytosis process by 
macrophages such as TLR6 [169]. 
Macrophages have the ability to infiltrate tissues during inflammation 
[172]. Alveolar macrophages play a major role in the onset and progression of 
pulmonary diseases, such as asthma, chronic obstructive pulmonary disease 
(COPD), and pulmonary fibrosis [173]. Because inhalation is the common 
exposure route of ZnONP, alveolar macrophages are one of the first cells to 
come in contact with ZnONP in the lungs [159, 174]. The interaction between 
these cells and ZnONP is not well-understood. Some researchers have proposed 
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that the interaction between alveolar macrophages and ZnONP is mediated by 
non-specific binding, and some believe that it is mediated via scavenger 
receptors, such as the B1 scavenger receptor [134]. Moreover, ZnONP inhalation 
in mice infected with Haemophilus influenza (NTHi) reduced the bacterial 
clearance in BALF and in lung tissues by impairing alveolar macrophage 
activation [175]. 
Lung epithelial cells and ZnONP 
    Lung epithelial cells play an important role in immune responses upon 
ZnONP exposure. In vitro, ZnONP exhibited the highest toxicity to lung epithelial 
cells compared to other ENMs, such as TiO2, CeO2, and Al2O3NP [176]. The 
toxicity was linked to oxidative stress and DNA damage after ZnONP exposure 
[177, 178]. According to Wu et al., ZnONP induced IL-8 expression in bronchial 
epithelial cells through the phosphorylation of the proteins p65 and IkB-α, which 
are both part of the NF-КB signaling pathway [140]. A previous study showed that 
challenged mice with ZnONP after ovalbumin (OVA) administration, lead to 
induce Th2 responses in the lungs. These results indicated that ZnONP could act 
as adjuvants to OVA, [179]. 
Eosinophils 
    Eosinophils were first discovered in 1879 by Paul Ehrlich. Eosinophils 
account for around 3% of the leukocyte sub-population in human circulation with 
a half-life ranging from 8-18 hours, while in the tissues, the half-life could extend 
up to six days [180]. Eosinophils are characterized by a distinctive dark pink 
intracellular granule in standard hematoxylin and eosin (H&E) staining. 
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Eosinophils’ granules contain hydrolytic enzymes, such as the major basic 
protein (MBP), eosinophil peroxidase (EPO), eosinophil-derived neurotoxin 
(EDN), and cationic granule proteins [181]. Moreover, it has been acknowledged 
that eosinophilic granules not only contain hydrolytic enzymes but also contain 
various cytokines and chemokines. These pre-made cytokines and chemokines 
have many diverse biological functions and are available for rapid release upon 
stimulation [182-184]. Initially, it was believed that eosinophils only play a major 
role in controlling parasitic infections (helminth) and are involved in allergy 
diseases, such as asthma [185-188]. Later, eosinophils’ functions were found to 
be involved in many physiological processes, such as organ development [189, 
190], tissue repair and degradation [191-193], maintaining and recruiting 
lymphocytes [194-196], anti-microbial activity [197-199], fungal immunity [200, 
201], and tumor immunity [202]. 
Previous studies have suggested that ZnONP may promote eosinophilic 
airway inflammation in rodents. In OVA, challenged mice models, ZnONP 
exposure was found to increase the eosinophilic inflammation in the broncho 
alveolar lavage fluid (BALF) at seven days after oropharyngeal aspiration [154]. 
In another study, the intra-tracheal instillation of ZnONP induced the recruitment 
of eosinophils in the alveolar interstitium in C57BL/6 mice [153]. In contrast, 
according to Silva et al., ZnONP provides anti-apoptotic properties to human 
eosinophils by preventing caspase activation and Bcl-xL degradation, leading to 
delayed human eosinophils apoptosis [203]. In addition, ZnONP did not induce 




Cellular mediators induced by ZnONP (cytokines and chemokines)  
Interlukins-6 (IL-6) and Tumor necrosis factor alpha (TNF-α) 
    For most acute inflammatory conditions, both IL-6 and TNF-α are 
elevated. IL-6 induces fever reactions, while TNF-α promotes hypertension 
through endothelia cell activation [204]. Furthermore, IL-6 and TNF-α activate 
immune cells and are involved in the progression of many inflammatory 
diseases, such as rheumatoid arthritis [205]. IL-6 is a cytokine involved in many 
physiological processes, such as inflammation, infection, and regulation of 
metabolic, regenerative, and neural processes [206]. TNF-α is a pleotropic 
cytokine with diverse biological functions, including acute and chronic 
inflammation and the regulation of cell growth and proliferation [207]. As 
mentioned above, ZnONP induce toxicity in the cells via oxidative stress. The 
overwhelming oxidative stress response by the cells promotes the activation of 
several signaling pathways, such as MAPK and NF-κB, triggering cell signaling 
cascades that lead to an increase in cytokine expression, such as interleukins 
and TNF-𝛼 [208]. Several studies showed that ZnONP exposure induces the 
production of IL-6 and TNF-α both in vivo and in vitro [123, 138, 178, 209, 210]. 
Once ZnONP are engulfed by macrophages or exposed to epithelial cells, a 
variety of pro-inflammatory cytokines, such as IL-6 and TNF-α, and chemokines, 
such as CCL2, CCL3, CXCL1, and CCL11, are secreted; however, the exact 
sequence of the events that occur in these cells that result in the production of 
these cytokines/chemokines is not defined.  
29 
Monocyte chemoattractant protein 1 
    Monocyte chemoattractant protein 1(MCP-1), also known as CCL2, is a 
potent macrophage chemoattractant involved in the polarization and recruitment 
of murine macrophages during inflammation [211]. Previous data suggest that 
elevated levels of CCL2 are linked to chronic inflammatory diseases, such as 
obesity associated-type 2 diabetes and cardiovascular diseases [212, 213]. 
Regarding ZnONP exposure, earlier studies reported a significant increase in 
CCL2 levels after ZnONP exposure either in vivo (lung) or in vitro [158, 179, 
214]. According to Sahu et al., ZnONP promote the expression of the MCP-1 
mRNA level in THP-1 cells in vitro after exposure [215]. Moreover, in Balb/c 
mice, exposure to ZnONPs induced the production of CCL2 in lung, leading to a 
T helper cell (Th2) response. 
Eotaxin (CCL11) 
   Eotaxin (CCL11) is an eosinophils chemoattractant that was first defined 
in the BALF of OVA-sensitized guinea pigs to promote eosinophils recruitment 
[216]. In asthma and animal pulmonary allergic inflammation models, there is a 
positive correlation between the number of eosinophils recruited to the lungs and 
the local CCL11 level [217-220]. As stated, ZnONP promotes lung inflammation 
and induce the accumulation of eosinophils in BALF or the alveolar interstitium in 
rodent inflammation models with or without OVA sensitization, respectively. 
Saptarshi et al. reported the upregulation of CCL11 mRNA in the lung tissue after 
ZnONP exposure in mice. Furthermore, the CCL11 level was significantly 
elevated in BALF within 24 hours of ZnONPs exposure in mice [153, 221]. 
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Figure 3: Schematic model illustrating ENMs inducing an immunomodulatory 
response in the innate immune system: ENMs could induce an innate immune 
response by a direct interaction with innate immune cells, such as macrophage 
and mast cells, or by recruiting the innate immune cells to the site of exposure 
through cellular mediators, such as through cytokines and cell-specific 
chemokines, leading to the recruitment of more immune cells, such as 
neutrophils, basophiles, and eosinophils. Figure adopted from [95]. 
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Zinc oxide nanowires (ZnONWs) 
Zinc oxide nanowires (ZnONWs) with a one-dimensional (1D) shape have 
recently been synthesized by Advanced Energy Materials, LLC. (Fig 4). They 
have developed novel vapor-phase methods for generating these nanowires, 
which have numerous potential industrial applications; however, finite information 
is available regarding the potential biological effects of these novel nanowires. 
ZnONW share the same chemical composition as the commercial spherical 
ZnONP, which induce toxicity both in vivo and in vitro. The toxicity is mainly due 
to the solubility of ZnO particles in the acidic pH inside the phagolysosomal 
compartment of the cell. On the other hand, the change in the physical form of 
ZnONW to 1D may elicit different biological responses, especially an immune 
response [38, 92]. In addition, there are other ENMs that have a 1D shape, such 
as a carbon nanotube (CNT). Carbon nanotubes have been widely used in many 
areas such as biomedical and electronic devices [18, 19]. Due to the unique 1D 
shape and small size of CNT, it has been linked to many pulmonary diseases, 
such as lung fibrosis and asthma [222]. According to Rydman et al., CNTs induce 
inflammation in mice lungs by recruiting macrophages and eosinophils [223]. 
Furthermore, CNTs lead to inflammation and progressive fibrosis on the parietal 
pleura in mice. The cellular mechanism of CNTs inducing inflammation is ROS 
generation, which leads to activation in AP-1, NF-𝜅B, p38, and Akt signaling 
pathways [68]. Due to the large-scale production and increasing utilization of 
ZnONWs, concerns regarding ZnONW toxicity and whether ZnONWs are safe 
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are increasing. Thus, it would be highly beneficial to study and to investigate the 
safety of these ZnONWs. 
Figure 4: Scan electron microscopy (SEM) image of ZnONWs (left); 
transmission electron microscopy (TEM) of ZnONWs (right). 
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Significance and Aim of the study 
ZnONW has become one of the most important products in optical and 
electronic applications. They are being produced in large-scale quantities using 
different methods, such as vapor-phase, solution-phase, and hydrothermal 
methods, which could lead to occupational health risks. The potential exposure 
routes of these ZnONWs may vary depending on both occupational and 
environmental exposure. Human exposure to ZnONW and under acidic 
conditions in the cells (ZnO has a sensitive dissolution point) eventually trigger 
the release of Zn ions within the cells, leading to cell toxicity and death. 
Therefore, for this dissertation, the biological effect of ZnONW was assessed. 
First, the way such cellular and molecular responses are integrated into an 
inflammatory response in mouse models was determined. In addition, the cell 
types involved in the production of pro-inflammatory cytokines and chemokines 
were delineated. Therefore, the specific aims were as follows. 
AIM I: Investigate the potential of ZnONW to induce sterile inflammation in 
a mouse model. The large-scale production and ZnONW may lead to 
environmental pollution which increased risk of human exposure to ZnONW. 
Since the common exposure routes for these particles are skin contact, and lung, 
the inflammatory response in the following models. The consequences of 
local/systemic inflammatory responses to ZnONW were investigated. 
 Because the common exposure routes for these particles are skin contact 
(local) and inhalation, the inflammatory responses in the following models were 
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examined. First, local inflammation in the air pouch was used as a skin exposure 
model. Second, to simulate airway exposure, lung inflammation following the 
intra-tracheal instillation of ZnONW was analyzed. Lavage fluids were analyzed 
for inflammatory infiltrates as well as cytokines and chemokines were measured 
to identify the cellular mediators responsible for inducing inflammation. 
AIM II: Defining the cellular mediators and cell types activated by ZnONW 
exposure. 
The specific pathways that could lead to the sterile inflammation in vitro 
were assessed.  Previous studies showed that macrophage-specific (CCL2) and 
eosinophil-specific (CCL11) chemokines and TNF-α and IL-6 cytokines are 
induced upon ZnONP exposure, and because ZnONW share the same chemical 
composition of ZnONP, it was important to explore whether ZnONW induce the 
production of these chemokines and cytokines as well as to investigate the 
cellular and molecular basis for the production of these cytokines and 
chemokines by ZnONW. Using murine primary macrophages (BMDM), 
macrophage cell lines (RAW-264.7 cells), and lung epithelial cell lines (LKR-13), 
ZnONW was exposed to these cell lines, and the chemokine and cytokine 
production in culture supernatants was determined. The results were further 
confirmed using the qRT-PCR. Next to investigate the cellular uptake of ZnONW 
in BMDMs cells, FITC labeled ZnONWs were generated. Confocal microscopy, 
various staining techniques and pharmacological inhibitors were used to define 
the cellular uptake of ZnONW. Lastly, In-vitro toxicity experiments were 
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performed in bone marrow-derived macrophages, RAW-264.7, and LKR13 cells 
to evaluate the cell viability upon ZnONW exposure. 
36 
Figure 5: Schematic model of ZnONWs-induced sterile inflammation: ZnONWs 
induce inflammation in the lungs and the Air-pouch by recruiting immune cells, 
such as macrophages and eosinophils. The inflammatory exudates contain IL-6, 
TNF-α, CXC, and CCL. The cell types responsible for the production of these 
chemokines and cytokines and the pathways need to be identified. 
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CHAPTER 2 
MATERIALS AND METHODS 
Nanoparticles and Reagents 
Zinc Oxide nanoparticles ZnONPs (10-30 nm) and ZnONWs (100 nm) 
were provided by Advanced Energy Materials, LLC, a nanowire powder 
manufacturing company in Louisville, KY. Silicon dioxide nanoparticles 
(SiO2NPs 7nm &200 nm) was obtained from sigma Aldrich. All particles were 
made endotoxin-free by baking at 200°C overnight. The following 
pharmacological inhibitors were used in the study: Cytocholasin D, (from Sigma-
Aldrich) Bafilomycin-A1 (Santa Cruz). E.coli, LPS (LPS-EK; InvivoGen). 
Mice 
C57BL/6 mice were purchased from Jackson laboratories and bred at the 
University of Louisville. All mice were used in ex-vivo and in-vivo experiments 
were sex and age matched 6-8 weeks. All mice were maintained in a specific 
pathogen free facility and cared for in accordance with the institutional and 
National Institutes of Health (NIH) guidelines. The University of Louisville 
Institutional Animal Care and Use Committee (IACUC) approved all the 
procedures. 
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Fluorescein isothiocyanate (FITC) labeling of ZnONWs 
Four mg of ZnONWs were dispersed in 3 ml anhydrous 
dimethylformamide (DMF). Then a diluted solution of 0.5 μl of amino-propyl-
triethoxy-silane (APTS) in 25 μl DMF was added to the ZnONWs suspensions, 
which was followed by sonication, and stirring under nitrogen at room 
temperature for 20 h. ZnONWs were collected by centrifugation and  removing 
the supernatant. After washing, ZnONWs were re-suspended in 0.5 ml DMF and 
mixed with a solution of 1 mg FITC and 0.5 ml DMF. The suspension was stirred 
for 4 h, and the FITC-labeled ZnONWs were collected by centrifugation. FITC-
labeled. ZnONWs were thoroughly washed with DMF, dried under vacuum and 
stored as dry powders [224]. 
Bone marrow derived macrophages 
Six to eight-week-old C57BL/6 mice were euthanized by using CO2. The 
hind legs were dissected and the bone marrow cells were flushed out with cold 
Dulbeco’s Modified Eagle Medium (DMEM). The bone marrow cells were 
cultured in DMEM containing 10% FBS,100 units/ml penicillin, 100 mg/ml 
streptomycin, 2 mM L-glutamine and 50 mM β -mercaptoethanol supplemented 
with 25 ng/ml recombinant mouse macrophage colony stimulating factor 
(BioLegend; San Diego, CA). The cells were plated at a density of 1 million cells 
per 100-mm tissue culture dishes containing 10 ml of medium. After 3 days, 10 
ml of fresh growth medium was added to replace the medium. The cells were 
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maintained for another 3 days before the experiments. The purity of the cells 
(>99%) was confirmed using flow cytometry by surface staining for F4/80 and 
CD11b. 
Cell culture 
Raw 264.7, mouse macrophage cell line (American Type Culture 
Collection (ATCC), Manassas, VA, USA) and LKR13 cells, murine K-ras mutant 
lung adenocarcinoma cell line were maintained in Dulbecco’s Modified Eagle’s 
Medium (DMEM; Hyclone Laboratories, Inc., South Logan, UT, USA) 
supplemented with 10% heat-activated fetal bovine serum (FBS, Hyclone 
Laboratories Inc.) and 100 units/ml penicillin, 100 μg/ml streptomycin, 2 μM L-
Glutamine and 50 μM β - mercaptoethanol (Gibco®, Invitrogen Corporation, 
Carlsbad, CA, USA) at 37°C in a 5% CO2 incubator. Cells were seeded at 
0.5x106 cells/ well density into six well plates. 
In vitro ZnONWs, ZnONP and SiONP Stimulation Assay 
BMDMs were plated at a density of 0.5x106 cells per well in a six well 
culture dish in 2 ml of DMEM containing 10% FBS and allowed to attach 
overnight. BMDMs were primed with or without 10 ng/ml of LPS (LPS-EK; 
InvivoGen, San Diego, CA) for 3 hours. Cells were washed with pre-wormed 
PBS three times. Then the media was changed to 1% FBS media with final 




without t h e  pharmacological inhibitors Baf-A1 or CytD at the indicated 
concentrations for 1 hour prior to stimulation with 10 or 20 µg/ml of particles 
for  3-6 hours. 
RAW 264.7 cells were plated at a density of 0.5x 106 cells per well in a six 
well culture dish in 2 ml of Hyclone DMEM containing 10% FBS and allowed to 
attach overnight. The cells were primed with or without 10 ng/ml of LPS for 3 
hours. Cells were washed 3 times with pre-wormed PBS. Then the media was 
changed to 1% FBS media with final volume of 1000 µl in 6 well plate. The cells 
were then treated with 10 or 20 µg/ml of particles for 6-18 hours. 
 
LKR13 cells were plated at a density of 0.5 x106 cells per well in a six well 
culture plate in 2 ml of Hyclone DMEM containing 10% FBS and allowed to 
attach overnight. Cells were washed 3 times with pre-wormed PBS. Then the 
media was changed to 1% FBS media with final volume of 1000 µl in 6 well 
plate. The cells were then treated with 10 or 20 µg/ml of particles for 6 hours. 
 
Enzyme-Linked Immunosorbent Assay (ELISA) 
IL-6, TNF-α and IL-1β in the cell culture supernatants were measured 
using mouse IL-6, TNF-α and IL-1β ELISA MAX Standard Kit (Biolegend). LTB4 
in the cell culture supernatants was measured using LTB4 EIA Kit (Cayman 
Chemicals).  Briefly, Polyvinyl chloride (PVC) microtiter plates were coated with 
anti-cytokine antibody overnight at 4°C. The next day, the plates were washed 
using washing buffer, and non-specific binding blocked using blocking buffer 
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provided by the manufacturer. The standard dilution and the required dilutions 
were made for the following step. Cell culture supernatants were added to the 
coated plates, and plates were incubated for 2 hours at room temperature. The 
secondary antibodies (detection antibody) for IL-6, IL-1β and TNFα were added 
to the respective plates. Then plates were washed. The assay was developed 
according to the manufacturer’s instruction and the intensity of the signal was 
detected using ELISA plate reader at recommended wavelength (405 nm for IL-
6, TNF-α, or IL-1β and at 450nm for LTB4). The data was calculated by 
extrapolating the absorbance of each protein (cytokine) and the standard curve. 
 RT-PCR Assay 
Cells (BMDMS, RAW 264.7 and LKR13) were lysed using TRIzol reagent 
and total RNA was isolated using an RNeasy Mini Kit (Qiagen) using 
manufacturer’s protocol. RNA samples were treated with DNase (Qiagen) to 
remove any trace of DNA from the samples before reverse transcription with 
TaqMan reverse transcription reagents (Applied Biosystems) using random 
hexamer primers. Quantitative PCR was performed using ‘power SYBR-green 
master mix’ Applied Biosystems). Expression of the target genes was 
normalized to GAPDH and the relative fold changes relative to the PBS were 
calculated using the delta delta CT method. Data were representative of 
triplicate cell cultures. GAPDH, CXCL1, CXCL2, CCL2, CCL3, CCL4, CCL5, 
CCL11, TNFα and IL-6 primers obtained from Real Time Primers. 
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MTT assay 
The MTT assay is a colorimetric assay for assessing cell metabolic 
activity. BMDM, LKR13 and RAW264.7 cells were treated with ZnONWs for 
different time points 2, 4, 6, 18 hours. Then 3-[4, 5-dimethyltiazol-2-yl] 2, 5-
diphenyl-tetrazolium bromide (MTT) was added to the cells at the end of each 
time point. After 2h incubation with MTT, DMSO was added for 10 min. 
absorbance was measured at 562 nm using a BioTek microplate reader. 
Immunofluorescence 
BMDMs cells (0.7x106 ) were plated in a 35 mm cover-glass bottom dish 
(World precision Instruments, Sarasota, FL) in DMEM with 10% FBS and grown 
overnight. The media was changed to DMEM with 1% FBS and the cells were 
primed with 10ng/ml LPS for 3 hours. Then cells were treated with 1μM Baf-A1 
for 1h. Then cells were stimulated with 25 µg/ml FITC ZnONW for 3hrs. next 
cells were washed 3X with PBS and fixed with 10% formalin for 15 min. after 
fixation, cells were washed three times with 1X PBS, cells were stained with 
1:500 dilution 594-Cholera toxin Subunit B and 1:1000 dilution DAPI 
(ThermoFisher Scientific) and washed again before analyzing with confocal 
microscopy. The confocal images were captured using Nikon A1R confocal 
microscope at 60 x magnification with appropriate lasers as indicated. A 
minimum of five to six fields were captured for each sample. 
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Acridine orange staining 
Acridine orange is a fluorescence dye that is easily crosses the cell 
membrane. It used to stain acidic vacuoles (lysosomes, endosomes, and 
phagolysosome), with red to orange color and RNA, and DNA with green color in 
living cells.  BMDMs were treated with or without Baf-A1 for one hour followed by 
FITC-ZnONWs. Next cells were washed and loaded with 5 µg/ml acridine orange 
(Sigma- Aldrich) for 30 minutes. Cells were washed with Hank's balanced salt 
solution (HBSS) before imaging using confocal microscopy. 
Antibody staining 
BMDMs were treated with 1Μm BafA-1 for 1 hour followed by 25μg/ml 
FITC-ZnONWs treatment for 3 hours. Then, cells were fixed with 10% formalin 
for 15 min and permeabilized with 0.1% saponin. Non-specific binding was 
blocked using with 1% BSA for 1 hour. Next, cells were incubated with LAMP-1 
antibodies (a rat anti-mouse (1D4B) (abcam) at 1:500 dilution overnight at 40C. 
Later, cells were washed three times with 1X PBS and followed by an Alexa 594-
labeled secondary (rat anti-mouse IgG A-11032: ThermoFisher Scientific) at 
1:500 dilution for 1-2 hours. Cells were washed three times with 1X PBS and 





Air pouch experiment 
Five ml of sterile air was injected into the back of mice subcutaneously to 
generate an air pouch. Three days later another 3 ml of sterile air was injected 
into the pouch to maintain the air-pouch. After 3 days, 2 mg of particles in 500 μl 
of endotoxin-free PBS was injected into the air pouch. Control animals received 
500 μl of endotoxin-free PBS. After 6 hours of injection, mice were euthanized 
and the air pouch was lavaged with 3 ml of cold PBS.  
 
Particles installation in mouse lungs 
Mice were treated with antibiotics for one-week prior to surgery. Mice 
were surgically instilled (intratracheal) with endotoxin-free PBS (negative control) 
or 0.67 mg of endotoxin-free SiONPs (positive control) or 0.67mg of ZnONWs 
suspended in endotoxin-free PBS. Previous studies have reported the use of 0.2 
μg/mouse [225] and 0.168 μg/mouse of ZnONPs [226]. Particles suspension 
was vortexed before instillation to avoid settling of the particles. Mice were 
continuously maintained on antibiotics until euthanasia two days after instillation. 







Cells from air-pouch and BALFs were stained with various cell surface 
marker antibodies from BD Biosciences (San Diego, CA) or Biolegend (San 
Diego, CA). Data were acquired on FACS Calibur or FACS Canto (BD 
Biosciences) and analyzed using Flowjo software (Tree Star). Leukocytes were 
identified as CD45+ cells, lung macrophages as CD45+ FSChi CD11chi F4/80+ 
cells, neutrophils as CD45+ CD11c− Ly6Ghi Siglec-F− cells, eosinophil as 
CD11b, CD193, F4/80, Siglec-F, B cells as CD45+ FSClo B220+ cells, CD4 cells 
as CD45+ FSClo CD4+ and CD8 cells as CD45+ FSClo CD8+. In air-pouch 
lavage fluids, leukocytes were identified as CD45+ cells, macrophages as 
CD45+ FSChi F4/80+  CD11bhi Ly6Glocells and neutrophils as CD45+ SSChi 
Ly6Ghicells, eosinophil as  CD11b, CD193, F4/80, and Siglec-F. 
Cytospin 
The cytospin is a high speed centrifuge to concentrate the cells in a 
sample on a slide. It used to analyze the cell morphology and type. The air 
pouch lavage fluid cells and BALFs cells were spun down using Shandon 
Cytospin centrifuge (Shandon Lipshaw) followed by staining with Hema-3 




Lung lavage fluids and Air-pouch lavage from PBS or particles treated 
mice were measured for various levels of inflammatory proteins including TNF-α, 
CXCL1, CXCL2, CCL2, CCL4 and CCL5, CCL11, IL-1β & IL-1α. The analysis 
was accomplished following standard protocols at the Proteomics core facility of 
Medical University of South Carolina. 
Statistical Analysis 
Graph Pad Prism4 Software San Diego, CA was used to analyze the 
Data; Data were expressed as the means ± S.E from at least three independent 
samples. Statistical difference among groups was analyzed using the Mann–
Whitney U-test (in vivo) or Unpaired Student's t-test (in vitro/ex-vivo, RNA 
analysis). Two-tailed P values of <0.05 were considered as significant.
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CHAPTER 3 
ZnONWs INDUCE STERILE INFLMMATION 
IN DIFFERENTMOUSE MODELS 
Introduction: 
Physicochemical properties, such as size and shape, determine the 
interaction between ENMs and immune systems. The morphology of ENMs is 
one of the most important aspects for nano-toxicology. A novel class of a ZnO 
nanomaterials, called ZnONW, are being produced recently in high tonnage. 
They have a unique shape and size that differ from spherical ZnONP, which 
have been on the market for decades. The rapid production rate and enormous 
quantities substantially increase the risk exposure to ZnONW through different 
exposure routes that may vary depending on occupational and environmental 
exposure. During the production of ZnONW, workers could be exposed to free 




On the other hand, public exposure to ZnONW could occur through using 
products that contain ZnONW or through the release of ZnONW into the 
environment. The general exposure routes to ZnONW are inhalation, skin 
contact, and ingestion. The small size and unique shape make their exposure 
unavoidable, and a change in the shape could elicit different immune responses 
and could impact their uptake and recognition by the immune system. Moreover, 
limited data are available related to ZnONW toxicity as well as their acute 
inflammatory potential. In addition, long-term consequences of exposure to 
ZnONW are unknown.  
Therefore, the aim was to assess the adverse effects of ZnONW and their 
ability to induce inflammation. Such studies are required to ensure the safe 
production and use of ZnONW.  
The consequences of local /systemic inflammatory responses to ZnONW 
were investigated. First, the local inflammation in the air pouch was evaluated. 
The air-pouch provides a localized inflammatory setting that mimics skin 
exposure. Also, different cytokines and chemokines responsible for any cellular 
infiltration to the site of exposure were examined. Next, the consequences of 
systemic inflammatory responses to ZnONW were assessed using a lung 
inflammation model. Finally, the cellular mediators involved in the recruitment of 






ZnONWs induce inflammation in a murine air-pouch model 
One way that exposure to ZnONW can occur is through dermal contact; 
however, to the best of our knowledge, the possibility for ZnONW to be 
considered inflammatory irritants or to penetrate the skin have not been studied 
yet. Thus, whether exposure to ZnONW could lead to any local inflammatory 
response was explored. A murine air pouch model was used to assess the 
potential localized inflammation caused by ZnONW. The air pouch provides a 
localized environment allowing to study infiltration of immune cells in response to 
any inflammatory agent or irritant. In this experiment, the air pouch was 
established by injecting 5 ml of sterile air subcutaneously into the back of the 
mice. After three days, another 3 ml of sterile air was injected into the pouch. 
Three days later, 2 mg of ZnONW in 500μl of endotoxin-free PBS was injected 
into the air pouch. As controls, PBS alone (negative) or SiONP (2 mg each) were 
injected into the air pouch. The mice were euthanized six hours after particle or 
PBS administration, and air pouch lavage was collected with 3 ml of PBS (Fig. 
6). A flow cytometry analysis and the cytospin of the air-pouch lavage revealed, 
as expected from our previous study, that in SiONP-treated mice, there was 
induced neutrophilic inflammation but no significant infiltration of macrophages 
or eosinophils (Fig.7a&b). In contrast, ZnONW showed a significant increase in 
both macrophages and eosinophils. Although a neutrophil influx was observed 




results suggest that ZnONW-induced inflammation is both qualitatively and 
quantitatively different from that induced by SiONP. 
 
Inflammatory mediators induced by ZnONW exposure in an air pouch 
Because ZnONW induce inflammation by the recruitment of eosinophils 
and macrophages into the air pouch, which cellular mediators contribute to this 
distinct pattern of inflammation in the air-pouch was explored. Therefore, a 
multiplex analysis for the air pouch lavage from PBS or particle-treated mice was 
conducted. The analysis was performed in collaboration with Dr. Twal from the 
Medical University of South Carolina to test the levels of various inflammatory 
proteins. The following cytokines and chemokines were selected based on the 
cells detected in the air pouch: IL-1α, IL-1β, and TNF-α, IL-6, CXCL1, CCL2, 
CCL3, CCL4, and GM-CSF for macrophages; CXCL1-specific neutrophilic 
chemokine; CCL5 and CCL11 for eosinophils; and CCL2, CCL4, and CCL3 
macrophage-specific chemokines. The multiplex analysis showed that in the air 
pouch, there was a significant increase in CCL11, CCL2, and CXCL1 (Fig. 8a) 
and IL-6 and TNF-α, while for IL-1β, it was only detected with SiONPs (Fig. 8b), 
which is consistent with cells types recruited in the air pouch. These findings 
indicate that macrophages and eosinophils are the major cell types that 
contribute to inflammation induced by ZnONW in the air pouch; however, the 
actual events and pathways involved in the inflammation are not yet identified.   
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Lung inflammation induced by ZnONWs 
Inhalation is one of the most common exposure routes for ZnONW. 
Previous studies investigated inflammation induced by ZnONP in lung 
inflammation models; however, ZnONW has different physical properties than 
ZnONP but similar chemical compositions. Thus, whether ZnONW promote lung 
inflammation was examined using an acute two-day lung inflammation model. 
The mice were treated with antibiotics for a week before surgery to avoid 
infection after surgery, and after one week, the mice were surgically instilled 
(intra-tracheal) with endotoxin-free PBS (negative control) or 0.67 mg of 
endotoxin-free SiONP (positive control) or 0.67 mg of ZnONWs suspended in 
PBS without sonication. Particle suspension was vortexed before instillation to 
avoid the settling of the particles. The mice were continuously administered 
antibiotics until euthanized two days later. The lungs were lavaged, and 
bronchial alveolar lavage fluids (BALFs) were obtained. Both SiONP and 
ZnONW led to a massive influx of leukocytes in the lungs. Both the flow 
cytometry analysis and the cytospin of BALFs showed that macrophages and 
eosinophils were the predominant cells infiltrating the lungs with ZnONW, while 
SiONP only recruited neutrophils (Fig 9a). These data indicate that ZnONW 
have the ability to induce sterile inflammation that is distinct from the 
inflammation induced by other sterile nanoparticles, such as SiONP. 
Inflammatory mediators induced by ZnONW exposure in the lungs 
Similar to the air pouch model, the mediators that contribute to this 
distinct pattern of a sterile inflammatory response in the lungs were assessed. A 
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multiplex analysis for BALFs from PBS or particle-treated mice was performed to 
measure various inflammatory proteins. The following cytokines and chemokines 
were selected based on the cells detected in the lungs: IL-1α, IL-1β, TNF-α, IL-6, 
CXCL1, CCL2, CCL3, CCL4, and GM-CSF. For macrophage-specific 
chemokines, CCL2, CCL3, and CCL4 were selected. CXCL1 was selected for 
neutrophils, and CCL5 and CCL11 were selected for eosinophils. In the lungs, 
the levels of IL-6, TNF-α, CCL2, and CCL11 were elevated in ZnONW-treated 
mice; however, significant levels of IL-1β and CXCL1 were detected in BALF, 
which is consistent with neutrophilic inflammation that was induced by the 
SiONP administrated mice. These findings indicate that macrophages and 
eosinophils are the major cell types that contribute to inflammation induced by 
ZnONW in the lungs; however, the actual events and pathways involved in 
inflammation require further investigation.  
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Discussion: 
ZnONW has been introduced as part of everyday consumer products. It is 
important to protect workers and end users from the inhalation of potentially 
innocuous ENMs. To the best knowledge, inadequate data are available in the 
literature regarding the biological effects of ZnONW in vivo. To address this gap 
in knowledge, in this chapter, the consequences of local and systemic 
inflammatory responses to ZnONW investigated using in a mouse model have 
been discussed. Such studies are required to ensure the safe production and 
use of ZnONW. 
Local exposure such as dermal contact is considered a possible common 
exposure mode to ZnONW. Previous studies investigated dermal exposure to 
sunscreens containing ZnONP in both human and animal experimental models 
[227, 228]. ZnONP from sunscreen penetrate only the epidermis outer layer 
(stratum corneum) and were found in skin fold areas though not beyond them. 
These data suggested that skin exposure hazards of ZnONP are minimal and 
limited, and thus it is safe to use ZnONP in sunscreens [229-231]; however, 
most of these studies were done using healthy contact skin. Therefore, the skin 
exposure hazard of ZnONP for compromised and damaged skin is unknown. 
Further studies are necessary to elucidate this issue. 
In this study, and for the first time, a murine air pouch model was used to 
simulate local exposure to ZnONW. Earlier studies from the laboratory showed 
that crystalline silica exposure (CS) induced neutrophilic inflammation in the air 
pouch model with a significant increase in the levels of IL-1β and LTB4 [232]. 
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This type of inflammation observed with CS is linked to lipidosome activation and 
LTB4 production as well as to the NLRP3 inflammasome pathway, leading to 
caspase-1 activation [232, 233]. In this study, ZnONWs-induced inflammation 
resulted in the infiltration of macrophages and eosinophils and the production of 
CCL11, CCL2, IL-6, and TNF-α but not IL-β or LTB4. This is in contrast with 
significant neutrophilic inflammation induced by SiONPs treatment at the site of 
exposure (Fig. 7a, b) and significant levels of IL-β and LTB4 in the air pouch 
lavage (data not shown), as expected. Because IL-6 and TNF-α are produced 
after ZnONWs exposure, it appears that inflammation induced by ZnONWs is 
mediated via the NF-Κβ pathway. 
In addition to skin contact, inhalation is a general exposure route to 
ZnONW. Previous studies with ZnONP revealed that lung inflammation was 
detected in mice and rats exposed to ZnONP [153, 154, 234]. Most ZnONP 
animal studies were performed using allergic airway inflammation models that 
are prone to eosinophilic inflammation [153, 155, 158, 234]. It has been 
suggested that Zn2+ ions dissolved from ZnONP might be involved in ZnONP-
induced lung inflammation [92]. Nevertheless, the change in the morphology of 
ZnONW may influence the cellular uptake mechanisms and may cause a 
different immune response in vivo. Currently, workers are exposed to ZnONW, 
among other ENMs, without any permissible exposure limits. Respiratory 
diseases, such as fibrosis, asbestosis, and lung cancer, have been linked to 
inhalation exposure to fiber materials, such as carbon nanotubes and asbestos 
[235-237]. ZnONW has similar geometry properties as carbon nanotubes and 
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asbestos fibers. The intratracheal instillation of a 50mg/kg dose of CNTs induces 
pulmonary inflammation in mice through the recruitment of neutrophils and the 
activation of B cells [238]. Thus, ZnONW may need to be treated with the same 
caution as known inflammatory and carcinogenic materials, such as carbon 
nanotubes and asbestos. Based on the data from the murine inflammatory 
model, ZnONW induce a significant permeation of eosinophils and macrophages 
in BALFs, which was observed two days after ZnONW instillation without any 
prior sensitization (Fig. 9a, b). Furthermore, CCL11 (Eotaxin) and CCL2 
chemokines were identified as cellular mediators that are responsible for 
recruiting eosinophils and macrophages into the lungs after ZnONW exposure. 
In addition, elevated levels of IL-6 and TNF-α were detected in BALF. Previous 
studies with other ENMs, such as TiO2NP and NiONP, reported eosinophilic 
inflammation in mice with OVA sensitization or at day 4 post-lung instillation, 
respectively [239, 240]. The exposure of rod-like carbon nanotubes (rCNT) also 
triggered eosinophilic inflammation in wild-type mice after 4 h/day for four 
consecutive days of exposure, while tangled CNT (tCNT) did not elicit any 
inflammatory response [241]. The results suggest that the sterile inflammation 
induced by ZnONW is distinct from other ENMs-induced inflammation, and the 
major difference is related to the recruitment of eosinophils at the site of 
exposure by ZnONW compared to neutrophilic inflammation with SiONP. 
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Figure 6: Air pouch Model Experimental set-up. 
 Five ml of sterile air was injected into the back of mice subcutaneously to 
generate an air pouch. To maintain the air pouch 3 ml of sterile air was injected 
into the pouch Three days later. After 3 days, 2 mg of particles in 500 μl of 
endotoxin-free PBS was injected into the air pouch. Control animals received 
500 μl of endotoxin-free PBS. After 6 hours of injection, mice were euthanized 
and the air pouch was lavaged with 3ml of cold PBS. 
5 ml sterile air s.c.
into back of mice
3 ml sterile air to 
maintain air pouch 
• Air pouch is lavaged with 3
ml PBS
• Flow Cytometry.
• Cytospin analysis (analyze
the inflammatory cells).







Figure 7: Local inflammation induced by ZnONWs in the air pouch.  
Sterile air was injected s.c. on the back of the wild-type (WT) mice to form an air 
pouch and exposed to nanoparticles (ZnONWs or SiONP) or PBS as described 
in methods. Six hours post particle exposure the air pouch was lavaged with 3ml 
of buffer to assess infiltrating immune cells. The total number of leukocytes and 
differential count for cell types recruited in the air-pouch are indicated (a). 
Cytosine slides showing macrophage (red arrow), neutrophils (blue arrow) and 
eosinophils (black arrow) (b). Data are expressed as mean ± SE. *p<0.05, ***p< 







Figure 8: Inflammatory mediators induced by ZnONWs exposure in lung. 
Cytokines and chemokines levels were analyzed in air-pouch lavage from PBS or 
particles treated mice using Multiplex analysis. Levels of various inflammatory 
proteins CCL2, CCL4, CCL11, CXCL1 and CXCL2 levels (a). IL-6, TNF-α and IL-
1β levels (b). Data represent at least 5 mice 656 per group; error bars denote 
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Figure 9: Nano-particle induced acute lung inflammation. 
WT mice were intratracheal instilled with nanoparticles (ZnONW or SiONP) or 
PBS as described in methods. Lungs were lavaged with 3ml of buffer to assess 
infiltrating immune cells as identified by flow cytometry of BALFs (a). Total 
number of leukocytes and differential count for cell types recruited in the lung are 
indicated above. Representative cytospin slides showing macrophages (red 
arrow), neutrophils (blue arrow) and eosinophils (black arrow) (b). Data are 
expressed as mean ± SE. *p<0.05, ***p< 0.001 non-parametric t-test. Data are 






Figure 10: Inflammatory mediators induced by ZnONWs exposure in lung. 
Cytokines and chemokines levels were analyzed in BALFs from PBS or particles 
treated mice using Multiplex analysis. Levels of various inflammatory proteins 
CCL2, CCL4, CCL11 and CXCL1 levels (a). IL-6, TNF-α and IL-1β levels (b). 
Data represent at least 5 mice 656 per group; error bars denote mean ± SEM. *P 
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CELLULAR AND MOLECULAR MEDIATORS INDUCED BY 
ZNONWs EXPOSURE 
Introduction: 
ZnONP toxicity has been extensity studies in a different mammalian cell 
lines [242]. The uptake mechanism and biological effect of ZnONP has also 
been studied in several in vivo and in vitro studies; however, novel ZnONW, 
which have a one-dimensional shape, were investigated in this study. The 
uptake and recognition mechanisms of these nanowires have not yet been 
identified. Moreover, most toxicity studies conducted with ZnONP showed that 
their toxicity is due to the solubility of ZnONP to zinc ions [52, 92, 93, 243, 244]. 
Still, the change in the physical properties of ZnONW may actually alter their 
interactions with immune cells. Subsequently, this could impact the uptake 
pathways of ZnONW, leading to differences in biological responses to ZnONW. 
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Very limited data are available related to ZnONW toxicity and 
translocation within the cells. ZnO nano-rods were found to be more toxic than 
ZnONP in Hela cells [243]. Exposure to rod-shaped ZnONP (100-200 nm) 
induces toxicity in human aortic endothelial cells at 10 and 50 μg/mL 
concentrations [244]. Furthermore, ZnONW were found to be toxic to HMMs at a 
concentration of 20μg/ml after 24 hours of exposure [92]. Pathogen uptake and 
degradation occur through the phagosomal maturation pathway such as 
endocytic pathway, and particles undergo the same process. It is a well-
organized process that allows for particle transition into the intracellular 
compartments of the cell. First, it begins with early endocytic vesicles that 
contain the particles in the peripheral cytoplasm. Then, the particles within the 
early endocytic content are delivered to early endosomes (EE) that have a 6.2 
pH level. EEs receive cargo from differed pathways, such as the clathrin and 
caveolar mediated pathways or the EEC and ARF6-dependent pathways. The 
content of EE is carried to large vesicles called late endosomes (LE), where the 
pH level is gradually reduced to 5.5. Next, in the perinuclear region, the plasma 
membrane and other compartments are recycled and sent back to the cell 
surface through recycling endosomes. Lastly, LEs fuse to the lysosomes with a 
final pH level equal to 4.5, and the contents are digested by the lysosomal 
hydrolases [245]. 
 Under acidic conditions, such as the lysosomal vacuoles of the cells, 
ZnO has a highly sensitive dissolution point. The release of the zinc cation from 
ZnONP induces phagosomal membrane destabilization, leading to autophagy 
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and cell death [246]. Furthermore, the production of lysosomal proteases 
promotes ROS generation and induces the activation of inflammatory pathways. 
According to Roy et al., ZnONP triggers the production of ROS and enhance 
inflammatory signaling pathways, such as the MAPK kinases and NF-κB 
cascades, as well as the production of pro-inflammatory cytokines, such as IL-8, 
IL-6, and TNF-α [141]. Furthermore, they found that caveolae-mediated 
endocytosis is the primary mechanism in which ZnONP is taken up by peritoneal 
macrophage. 
 In chapter three, it has been demonstrated that ZnONW induced sterile 
inflammation by recruiting macrophages and eosinophils both in lung and air- 
pouch mouse models. In addition, ZnONW induced macrophage-specific (CCL2) 
and eosinophil-specific (CCL11) chemokines and cytokines, such as IL-6 and 
TNF-α, in the air pouch and lungs because tissue-resident macrophages and 
epithelial cells coordinate the inflammatory response. Thus, it is imperative to 
determine which cell types produce these chemokines and cytokines in 
response to ZnONW. The identification and understanding of the cellular 
mediators that are involved in inflammation induced by ZnONW would help in 
defining the underlying inflammatory mechanisms activated by ZnONW. This 
understanding might also provide useful insights into and knowledge of the 
inflammatory potential of other ENMs with similar shapes and sizes as ZnONW. 
In this study, the cellular uptake, subcellular localization, and 
inflammatory and toxic effects of ZnONW on cellular models were investigated. 




LKR13 cells were chosen to represent bronchial epithelial cells. First, to track 
ZnONW’ cellular uptake and localization, it was necessary to generate 
fluorescent-labeled ZnONW (FITC-ZnONW). BMDM was exposed to FITC-
ZnONW, and the uptake and localization of these particles in the lysosomes was 
detected using confocal microscopy. To prevent the solubilization of ZnONW, 
Bafilomycin-A1 (Baf-A1), a macrolide antibiotic isolated from the streptomyces 
species that inhibits the vacuolar H+ATPase (V-ATPase), was used to inhibit the 
acidification of phagosomes. Next, the cell types that are involved in the 
production of IL-6 and TNF-α cytokines and chemokines CCL11 and CCL2, 
which were integrated into the inflammatory response in vivo in mouse models, 
were identified. BMDM, RWA264.7, and LKR13 cell supernatants were used to 
measure the levels of TNF-α, IL-6, IL-1β, and LTB4 and CCL11 and CCL2. 
Then, the requirement of phagocytosis for IL-6 and TNF-α production was 
investigated using CytD. Cell lysate was used to measure the fold changes in 
the expression levels of mRNA of TNF-α, IL-6, CCL2, CCL3, CCL4, CXCL1, and 










Preparation and characterization 
ZnONWs were synthesized using downstream microwave plasma reactor 
methods with a rapid oxidation of zinc powders in a gas phase [23]. The 
dimensions of ZnONWs as determined by Scanning Electron Microscopy (SEM) 
were around 20-120 nm in diameter and 5000 nm in length (Figure 11). 
Cytotoxicity of ZnONWs for BMDM, LKR13, and RAW 264.7 cells 
Previous studies showed the toxicity of ZnONP for mammalian cells in 
vitro [13, 25-27].  ZnONP induced toxicity in a variety of cells, such as kidney, 
liver, and lung cell lines [12, 13, and 26]. To investigate whether ZnONW exhibit 
distinct cytotoxicity profiles, both dose response and time course studies were 
conducted. The MTT assay was used to measure the metabolic activity of cells. 
First, macrophage cell lines (RAW-264.7 cells) were stimulated with different 
doses of ZnONW of 5, 10, 20, and 100 μg/ml for six hours. It was observed that 
at 5, 10, and 20 μg/ml, and the cells were 95% viable, whereas 100 μg/ml 
reduced the cells’ viability by approximately 20% (Fig. 12a). As a result, 20 μg/ml 
and 100 μg/ml doses were selected to perform the time course studies. As 
shown (Fig. 12b), nearly 100% of the cells were viable after 18 hours of 
treatment with 20 μg/ml dose of ZnONW, whereas more than a 50% cell death 
was observed at 100 μg/ml. The cytotoxicity of ZnONW was also determined in 
other cell types, such as BMDM and LKR13 cells. In LKR13, a similar toxicity 




μg/ml concentration of ZnONW induced significant toxicity after 18 hours of 
exposure by a reduction in cell viability up to 30%, whereas 100 μg/ml induced 
toxicity after only 4 hours of ZnONWs stimulation (Fig. 13b). Thus, all further 
studies with different cell types were performed with 20 μg/ml or less doses of 
ZnONW for 6 hours of treatment. 
 
Cellular uptake and translocation of ZnONWs 
  To investigate the cellular uptake of ZnONW in BMDMs cells, FITC-
labeled ZnONW was generated as previously described [20]. Since ZnONW 
tend to dissolve in the acidic condition, we used Baf-A1 to block the acidification 
and to facilitate the visualization of ZnONWs in the cells. In order to investigate 
the effect of Baf-A1 on blocking the acidification of the phagolysosome Acridine 
orange staining was used. Cells were primed with LPS for three hours followed 
by a one-hour pre-treatment with or without Baf-A1. Then, cells were exposed to 
25 µg/ml FITC-labeled ZnONW for three hours and washed. Followed by 
Acridine orange staining and examined by confocal microscopy. As shown in Fig 
14 ZnONWs treated cells showed enlarged lysosomal compartments whereas in 
Baf-A1 treated ZnONWs exposed cells no lysosomal staining was observed. 
These data suggested that Baf-A1 prevent block the acidification of the 
phagolysosome. To evaluate the uptake of the ZnONWs, cells were primed with 
LPS for three hours followed by a one-hour pre-treatment with Baf-A1. Then, 
cells were exposed to 25 µg/ml FITC-labeled ZnONW for three hours and 
washed and examined by confocal microscopy. As shown in Fig 15, intracellular 
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ZnONW was detected only in cells pre-treated with Baf-A1, whereas cells that 
were not treated with Baf-A1 did not show an intracellular accumulation of 
ZnONW particle. These results suggest that the inhibition of phagolysosome 
formation prevents the dissolution of intracellular ZnONWs in the cells. 
Next, to track the trans-location of FITC-ZnONW in the cells, LAMP-1 
staining, LAMP-1 stains late endosomal and lysosomal compartments in the cell, 
was used. Baf-A1-treated BMDMs were stimulated with FITC-ZnONW followed 
by LAMP-1 staining. The ZnONW treatments exhibited lysosomal clumping 
(Fig.16a). The LAMP-1 staining was overlapped by the FITC- ZnONW (Fig.16b). 
ZnONW induces the release of pro-inflammatory mediators by 
macrophages in vitro 
To examine the inflammatory potential of ZnONW, BMDMs were treated 
with ZnONW, and the levels of pro-inflammatory cytokines, such as IL-1β, IL-6, 
and TNF-α, as well as the lipid chemokine LTB4 were measured in culture 
supernatants. Our previous study showed that SiONP induce the production of 
IL-1β and LTB4. Thus SiONP was used as positive controls for the production of 
IL-1β and LTB4 [19, 28]. The treatment of BMDMs with ZnONW or ZnONP did 
not result in any significant accumulation of IL-1β or LTB4 (Fig. 17a). As 
expected, SiONP treatments induced the production of IL-1β and LTB4 in 
BMDMs (Fig. 17a). ZnONW induced a dose-dependent increase in the 
production of the cytokines IL-6 and TNF-α (Fig. 17b). Furthermore, treatment 
with Baf-A1 significantly reduced the ZnONW-induced production of these 
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cytokines (Fig. 17b). A similar dose-dependent cytokine induction profile was 
observed in RAW 264.7 cells treated with ZnONW (Fig 18); however, the 
exposure of lung epithelial cell line LKR13 to ZnONW did not result in either IL-6 
or TNF-α production. These results suggest that ZnONW could induce the 
synthesis of pro-inflammatory cytokines IL-6 and TNF-α but not IL-1β or LTB4. 
The soluble Zn ions are mediating the toxicity of ZnONWs. However, did Zn ions 
induce the production of these cytokines? In order to investigate the ability of 
soluble zinc induce the induction of IL-6 and TNF-α. BMDMs were treated with 
ZnCl₂ for six hours. Then IL-6 and TNF-α were measured in culture supernatants 
supernatant. Interestingly, treatment of cells with ZnCl₂ did not induce the 
production of these cytokines (Fig 19). 
ZnONWs upregulate TNF-α, IL-6, CCL11, and CCL2 at mRNA expression 
level 
Previous studies showed that CS exposure in the lungs leads to an 
increase in LTB4, IL-1β, and many CXC chemokines [232]. Because ZnONW-
induced inflammation is significantly different from that of CS-induced 
inflammation, the mediators that contribute to this distinct pattern of inflammatory 
responses were examined. The mRNA levels of various cytokines and 
chemokines that regulate macrophage and eosinophilic inflammation were 
measured based on the cell types detected in in vivo studies. In BMDMs (Fig 20) 
and RAW 246.7 cells (Fig 21), the ZnONW and ZnONP resulted in significantly 
increased CCL4 and CCL11 and IL-6 and TNF-α expression. In addition, in the 
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culture supernatant, the CCL11 level was significantly increased, whereas CCL2 
was not significant (Fig 20). In contrast, the exposure of the lung epithelial cell 
line LKR-13 led to an enhanced expression of CCL2 and CCL11 mRNAs and 
protein levels in cell supernatants by ZnONW and ZnONP (Fig 22). The CCL11 
protein was upregulated in culture supernatants of ZnONWs exposed BMDMs 
and LKR13 cells (Fig 23). Whereas CCL2 were levels increased only in 
supernatants from LKR13 cells but not in BMDMs (Fig 23).These findings 
suggest a basis for the recruitment of macrophages and eosinophils due to the 
exposure of ZnONW. 
Phagocytosis is required for ZnONWs-induced TNF-α and IL-6 production 
To assess the cellular uptake mechanisms of ZnONW, cells were pre-
treated with cytochalasin D (CytD) (phagocytosis inhibitor) and Baf-A1 [19, 24]. 
CytD treated cells did not show intracellular FITC-ZnONW, suggesting that 
phagocytosis is required for their uptake (Fig 24a).Furthermore, treatment with 




ZnONP has been known to induce toxicity and cell death to different 
mammalian cell lines [12, 32, 40-42]. It has been suggested that the solubility of 
ZnO in the acidic vacuoles is the underlying cause of ZnONP toxicity; however, 
the physical properties play a major role in ENPs toxicity. Thus, whether the 
change in the shape of high aspect ZnONW elicits a different toxicity behavior 
than ZnONP was investigated. It was found that ZnONW induced toxicity in 
different cell types, including BMDM, RAW 267.4, and LKR13 cells (Fig. 12, 13). 
Significant cell death was observed at 20 μg/ml of ZnONW after 18 hours of 
exposure; however, at 100 μg/ml, the cell viability was further reduced even at 
four hours of ZnONW exposure (Fig. 12). These results are in agreement with 
other previous studies, which suggested that ZnONW induce toxicity in cultured 
cells [4, 43]. Thus, all further studies with different cell types were performed at 
20 μg/ml or less doses of ZnONW for six hours of exposure. 
Macrophages play an important role in innate immune responses against 
ENMs [32]. The uptake mechanisms of the ENMs largely depend on the 
physiochemical properties of the particles, such as shape and size. Previous 
studies showed that the cellular uptake of ENMs, such as ZnONP, gold 
nanoparticles, sliver nanoparticles, iron oxide nanoparticles, and carbon 
nanotubes, is facilitated via clathrin, caveolae, and/or scavenger receptor-
mediated endocytic pathways [141, 247-252]. In addition, very little free Zn ions 
exist in the cytosol of healthy cells, and they are mostly found to be bounded to 
proteins, such as metallothionins, or to be sequestered in cellular organelles, 
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such as mitochondria and lysosomes [253]. According to Xia et al., only small 
faint particles remnants were detected in RAW 264.7 after exposure to FITC-
labeled ZnONP [224]. This could be explained by the dissolution of ZnONP 
inside the acidic vacuoles of the cells. Therefore, Baf-A1 was used to block the 
acidification of the acidic compartment of the cells (lysosome). To assess the 
effect of Baf-A1 on lysosomal acidification, acridine orange staining was used. 
Acridine orange emits green fluorescence in nuclear and cytoplasmic 
compartments, while acidic lysosomes or phagolysosome are stained orange to 
red. ZnONW-treated cells showed red enlarged lysosomal compartments. 
Acridine orange staining in the lysosomal compartments was completely absent 
in Baf-A1-treated cells exposed to ZnONW (Fig. 14). This indicated that Baf-A1 
inhibited the acidification of the acidic compartment in the cells. 
ZnONW was detected in intracellular compartments only in the presence 
of Baf-A1 (Fig. 15 a and b), an inhibitor of vacuolar acidification. It was concluded 
that in the absence of Baf-A1, the ZnONW taken up by these cells are readily 
solubilized to generate Zn ions. 
The inflammatory pathways triggered by ENMs, such as SiONP, titanium 
dioxide nanoparticles (TiONP), and carbon nanotubes (CNT), were all linked to 
the activation of the inflammasome –caspase-1 related pathway (NLRP3) and 
the release of the cytokine IL-1 β [95, 96]. The current studies showed that the 
stimulation of BMDMs and RAW 267.4 cells with ZnONW did not induce IL- β or 
LTB4 production, whereas SiONP induced  both IL- β and LTB4 (Fig. 17a), as 
expected. These results suggest that ZnONW do not activate the NLRP3 
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inflammasome pathway; however, ZnONP is known to induce the production of 
IL-6 and TNF-α [138, 254, 255]. The results also showed that ZnONW exposure 
leads to a significant increase in the production of both IL-6 and TNF-α in a dose-
dependent manner in RAW267.4 (Fig. 18) and BMDM but not in LKR13 (Fig.17b) 
cells; however, in the presence of Baf-A1, exposure to ZnONW did not result in 
any IL-6 or TNF-α production, suggesting that soluble Zn ions mediate the 
induction of these cytokines (Fig.17b). Interestingly, the treatment of cells with 
ZnCl2 did not induce the production of these cytokines (data not shown). Thus, 
the uptake of the particles as well as their dissolution within the phagolysosomeal 
compartment appears essential for the induction of cytokines, and the externally 
provided ZnCl2 is not sufficient for activating the production of pro-inflammatory 
cytokines. Furthermore, both ZnONP [138, 254, 255] and ZnONW (current study) 
induced a similar cytokine profile, which suggests that it is the chemical nature 
rather than the shape of the ZnO ENMs that is the primary cause of the observed 
cytokine profile. Together, these results suggest that ZnONW induce a distinct 
inflammatory pathway from SiONP and other ENMs. 
The molecular basis for the in vivo ZnONW-mediated cellular infiltration 
was further analyzed in vitro in different cell types. The CCL11, CCL2, IL-6, and 
TNF-α expression levels in BMDM (Fig. 19), RAW 267.4 (Fig. 20), and LKR13 
cells (Fig. 21) stimulated with ZnONW was examined. The data suggested that 
lung epithelial cells and resident macrophages could be the primary responders 
to ZnONW, producing CCL2 and CCL11 and leading to macrophage and 




considered one of the major sources for TNF-α production upon activation. When 
cells are exposed to TNF-α, NF-kβ is activated, leading to the expression of 
many pro-inflammatory cytokines genes, such as IL-6 [256]. Furthermore, the 
upregulation of CCL11 and CCL2 mRNA expression is mediated via the 
intracellular signaling of TNF-α through the NF-Κβ pathway [257]. Because NF-
Κβ is a transcription factor known to regulate both CCL11 and CCL2 promoters 
and to signal downstream of both the IL-6 and TNF receptors [257-259], further 
studies are needed to define the NF-Κβ signaling pathways that are activated 
upon ZnONW exposure and therefore involved in the production of CCL11, 
CLL2, IL-6, and TNF-α. 
Phagocytosis typically involves the uptake of larger particles (>250nm). 
Aggregates of the FITC-ZnONW in the vacuoles (Fig. 15a) were consistently 
observed, suggesting that they may be taken up by the actin-dependent 
endocytic pathways. Consistent with this notion, treatment with CytD completely 
blocked the uptake of FITC-ZnONW (Fig. 23a). Moreover, CytD exposure to 
ZnONW did not result in any IL-6 or TNF-α production (Fig. 23b), suggesting that 
phagocytosis is required for the uptake and the production of IL-6 and TNF-α. 
In summary, ZnONW induced the production of pro-inflammatory 
cytokines IL-6 and TNF-α and and eosinophil-specific CCL11 in BMDMs. In 
contrast LKE13 cells induce the production of CCL2 and CCL11 only but not IL-6 
and TNF-α. These results suggest that lung epithelial cells could be the primary 
source for CLL2 and CLL11 which lead to recruitment of macrophage and 
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eosinophils to the site of exposure. And macrophages as the secondary 


















Figure 11: Scanning Electron Microscopy (SEM) of ZnONWs. 
Scanning Electron Microscopy (SEM) image of ZnONWs indicating size of 
individual nanowires. The dimensions of ZnONWs as determined by Scanning 












Figure 12: Cytotoxicity assessment of ZnONW. 
0.5x106 cells /ml of RAW-264.7 cells were stimulated with different 
concentrations for different times with ZnONW as indicated or with PBS as 
negative control. Cell viability was assessed using MTT test. RAW-264.7 cells 
were stimulated with ZnONW 5, 10, 20 and 100 μg/ml for 6 hours (a). Time 
course study for RAW-264.7 cells, cells were stimulated with ZnONW 20μg/ml & 
100μg/ml concentrations for 2, 4, 6 & 18 hours (b).  Data represented is from 
one of the three experiments. Data are expressed as mean ± SE. **p< 0.01, 
***p< 0.001 non-parametric-test.  


























































Figure 13: Cytotoxicity assessment of ZnONW. 
0.5x106 cells /ml of BMDMs from WT mice, LKR13 cells were stimulated with 
different concentrations for different times points with ZnONW as indicated or 
with PBS as negative control. Cell viability was assessed using MTT test. LKR13 
cells were stimulated with ZnONW 20μg/ml & 100μg/ml concentrations for 2, 4, 6 
& 18 hours (a). BMDMs were stimulated with ZnONW 20μg/ml & 100μg/ml 
concentrations for 2, 4, 6 & 18 hours (b). Data represented is from one of the 
three experiments. Data are expressed as mean ± SE. **p< 0.01, ***p< 0.001 
non-parametric-test. 
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Figure 14: Inhibition of phagolysosome formation using Baf-A1 inhibitor. 
LPS-primed BMDMs were stimulated with 25 μg/ml ZnONW for 3 h in the 
presence (b) or absence of Baf-A1 (a). Cells were stained with acridine orange 
for 30 min after ZnONWs exposure. Acridine orange stains the acidic vacuoles in 
the cells such as phagolysosome with orange to red color whereas DNA/RNA or 
cytoplasm of the cell with green color. Cells were visualized by Nikon A1 confocal 
microscopy. A minimum of five fields were captured for each sample in every 
experiment. 
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Figure 15: Cellular uptake of ZnONWs. 
 LPS-primed BMDM cells were stimulated with 30µg/ml FITC-ZnONW for 3h in 
the presence or absence of Baf-A1 (1μg/ml). Cells were stained with cholera-
toxin B (red) and DAPI (blue) for 20min after fixation and visualized by Nikon A1 
confocal microscopy (a). The density of intracellular ZnONW particles was 
calculated as number of particle events/ high power field as indicated in (b). Data 
represented is from one of the three experiments. Data are expressed as mean 
± SE. **p< 0.01, ***p< 0.001 non-parametric-test. 
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Figure 16: Sub-cellular localization of ZnONWs. 
 LPS-primed BMDM cells were stimulated with 30 µg/ml FITC-ZnONW for 3h in 
the presence or absence of Baf-A1 (1 μg/ml). After fixation and permeabilization, 
cells were stained with 1 μg/ml 1 μg/ml anti LAMP-1 antibody followed by Alexa 
594 labeled antibody to visualize lysosomes (red) and DAPI (blue) (a). The 
intensity plot shows the overlapping of green and red signals (b). 
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Figure 17:  ZnONWs exposure induced the release of pro-inflammatory 
mediators by macrophages in vitro.  
Pro-inflammatory cytokines levels from PBS or particles (ZnONP, ZnONW & 
SiONP) exposure in culture supernatants were analyzed using ELISA. IL-1β and 
LTB4 levels were measured in BMDMs exposed for 6hrs.  Cells were primed with 
LPS (10ng/ml) for 3h and washed and then treated with ZnONW, ZnONP, SiONP 
or PBS (a). BMDMs cells were primed with LPS (10ng/ml) for 3h and washed 
then treated with or without Baf-A1. Then cells were treated with ZnONW or PBS 
for 6hrs, IL-6 and TNF-α levels were measured as indicated (b).  Data 
represented is from one of the three experiments. Data are expressed as mean ± 
SE. **p< 0.01, ***p< 0.001 non-parametric-test. 
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Figure 18: ZnONWs exposure induced the release of pro-inflammatory 
mediators by macrophages in vitro.  
Pro-inflammatory cytokine levels from PBS or particles (ZnONP, ZnONW & 
SiONP) treated RAW264.7 cell culture supernatants were analyzed using 
ELISA. RAW 264.7 cells were stimulated with LPS (10 ng/ml) for 3h. Then cells 
were treated with ZnONW, ZnONP, SiONP or PBS for 6hrs (a) or 18 hrs (b) and 
the IL-6 and TNF-α levels were measured in the supernatants. Data represented 
is from one of the three experiments. Data are expressed as mean ± SE. **p< 




















Figure 19: ZnCl2 did not induced the release of IL-6 or TNF-α by 
macrophages in vitro. 
BMDM cells were stimulated with LPS (10ng/ml) for 3h. Then cells were treated 
with ZnONW, ZnONP, ZnCL, SiONP or PBS for 6hrs, IL-6 (a) and TNF-α (b) 
levels were measured as indicated in the culture supernatants using ELISA. 
Data represented is from one of the three experiments. Data are expressed as 
mean ± SE. **p< 0.01, ***p< 0.001 non-parametric-test.   
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Figure 20: Inflammatory mediators induced by ZnONWs exposure.  
Cytokines and chemokines expression levels were analyzed in BMDM cells and 
LKR13 cells from PBS or particles treated cells using qRT-PCR. Various level of 
inflammatory genes mainly IL-6, TNF-α, CCL2, CCL4, CCL11, CXCL1 & CXCL2. 
(a) Cytokines and chemokines levels from BMDMs cells. (b) from LKR13 cells. 
Data represented is from one of the three experiments. Data are expressed as 
mean ± SE. **p< 0.01, ***p< 0.001 non-parametric-test. 
85 
Figure 21: Expression levels of inflammatory marker induced by ZnONWs 
in RAW 264.7 cells. 
Expression of cytokines and chemokines mRNA levels were analyzed in RAW 
264.7 cells exposed to PBS or particles treated cells using qRT-PCR. 
Inflammatory marker IL-6, TNF-α, CCL2, CCL4, CCL11, CXCL1 and CXCL2. 
Data represented is from one of the three experiments. Data are expressed as 
mean ± SE. **p< 0.01, ***p< 0.001 non-parametric-test. 
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Figure 22: Inflammatory mediators induced by ZnONWs exposure.  
Cytokines and chemokines levels were analyzed in LKR13 cells from PBS or 
particles treated cells using qRT-PCR. Various level of inflammatory genes 
mainly IL-6, TNF-α, CCL2, CCL4, CCL11, CXCL1 & CXCL2. Data represented is 
from one of the three experiments. Data are expressed as mean ± SE. **p< 0.01, 
***p< 0.001 non-parametric-test. 
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Figure 23: CCL11 and CCL2 levels induced by ZnONWs in BMDMs and 
LKR13 cells. 
The levels of CCL11 and CCL2 proteins were determined in the culture 
supernatants from (a) BMDM and (b) LKR13 cells using ELISA. Data 
represented is from one of the three experiments. Data are expressed as mean ± 







Figure 24: Phagocytosis is required for ZnONWs induced TNF-α and IL-6 
production. 
10 ng/ml LPS-primed BMDM cells were stimulated with 25 µg/ml FITC-ZnONW 
for 2h in the presence or absence of CytD (10µg/ml). Cells were stained with 
cholera-toxin B (red) and DAPI (blue) for 20 min after fixation and visualized by 
Nikon A1 confocal microscopy (a). BMDMs cells were primed with LPS 
(10ng/ml) for 3h and washed then treated with or without (1 μM) Baf-A1. Then 
cells were treated with ZnONW or PBS for 6hrs, IL-6 and TNF-α levels were 
measured as indicated (b). Data represented is from one of the three 






In the last two decades, with the advent of nanotechnology, the use of 
ENMs have become widespread due to their applicability in many areas 
including industry, agriculture, and medicine. ENMs are materials that were 
created and designed with specific shapes and sizes to produce new materials 
at nano-scale. The rapid development and the increase in use of ENMs in 
consumer products have created a gap and challenge through limited knowledge 
about the safe and sustainable use of ENMs. Previous studies indicated that 
some ENMs can be cytotoxic. Furthermore, some forms of ENMs can cross the 
blood-brain barrier inducing neurotoxicity, brain tissue damage, and 
inflammation [260]. However, the long-term consequences of exposure to most 
of these particles are unknown. 
Zinc oxide (ZnO) has long been employed in many consumer products 
especially in sunscreen [225]. Despite the common use of ZnONP, the safety of 
these particles needs further investigation and the potential biological effects to 
humans are still unclear. 
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Moreover, the tremendous advancement in the field of nanotechnology 
has led to the emergence of new forms of ZnO ENMs called high aspect ratio 
ZnONW. These particles are being developed and introduced to the market with 
production rate estimated by millions of tons per year. The use of ZnONP is 
considered relatively safe, however with ZnONW, there is uncertainty about the 
safety of these ZnONW and their impact at the biological level. The rapid 
production of ZnONW pose a large of risk exposure for public and foundry 
workers. 
Here in this study we found that ZnONW induces toxicity and cell death to 
BMDM, RAW267.4, and LKR13 cells. Significant toxicity was observed at 20 
μg/ml of ZnONWs exposure for 18 hrs. However, at 100 μg/ml the cell viability is 
further reduced even at 4h of ZnONWs exposure. Based on previous studies 
done with ZnONP as mentioned in chapter 1, the toxicity is mainly due to the 
solubility of ZnONP inside the acidic vacuoles of the cells. We speculated that 
ZnONW induce toxicity similar to ZnONP since both ZnONW and ZnONP have 
the same chemical composition. 
The uptake mechanisms of the ENMs largely depend on shape, size and 
physiochemical properties of the particles. Previous studies showed that cellular 
uptake of ENMs such as ZnONPs, gold nanoparticles, sliver nanoparticles, Iron 
oxide nanoparticles and carbon nanotubes is facilitated through different uptake 
mechanism based on the size of ENMs [67, 248-250, 260, 261]. ENMs that have 
size less than 10 nm cross cell membrane via direct diffusion or non-specific 
pathways. Clathrin, caveolae and/or scavenger receptor-mediated endocytic 
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pathways were found mainly with ENMs that have a size between 50- 150 nm. 
Larger ENMs (200-2000 nm) were believed to be internalize thorough 
phagocytosis pathway. Our studies showed that visible uptake of FITC-ZnONW 
aggregate with cells that were treated with Baf-A1. Based on the aggregate size 
we speculated that these FITC-ZnONW aggregate may be taken up by the actin-
dependent endocytic pathways. Consistent with this notion, treatment with CytD 
completely blocked the uptake of FITC-ZnONW. These results indicated that 
phagocytosis appeared to be essential for uptake of ZnONW. 
Direct contact through skin and airway exposure are the most common 
routes of exposure to ZnONW. This current study provided the first experimental 
evidence that ZnONW induce localized inflammation in a murine air-pouch 
model, resulting in a broad inflammatory response by infiltration of 
macrophages, eosinophils, and neutrophils: production of CCL11, CCL2, IL-6 
and TNF-α. In contrast, intra-tracheal instillation of ZnONW in a healthy mouse 
without prior sensitization induced eosinophilic air-way inflammation and a tight 
and regulated inflammation in the lung by a massive influx in macrophages and 
eosinophils as well as remarkable increase in levels of CCL11, CCL2, IL-6 and 
TNF-α that are consistent with cell types infiltrated in the lung. The inflammatory 
response from ZnONW was distinct and different from SiONPs that induce 
neutrophilic inflammation both in lung and air-pouch. 
To have a better understanding of this type of inflammation, the 
inflammatory mediators induced upon ZnONW exposure were investigated. 
Inflammasome (NLRP3) and IL-1β release are considered as common pathway 
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in which ENMs induce sterile inflammation [100]. Previous studies from table 2 
above showed that some ENMs such as SiONP, CNT and TiONP induce the 
production IL-1β throw the activation of Inflammasome (NLRP3) pathway. On 
the other hand most of these studies did not investigated the possibility of 
endotoxin (LPS) contamination of ENMs, LPS contamination could lead to a 
misleading result since LPS could induce the activation of Inflammasome 
(NLRP3) pathway and production of IL-1β.  Here, ZnONW was made endotoxin-
free by baking at 200°C overnight to overcome the possibility of endotoxin (LPS) 
contamination.  Earlier studies from our laboratory showed that crystalline silica 
exposure (CS) induced neutrophilic inflammation in the air pouch model with a 
significant increase in the levels of IL-1β and LTB4 [232]. This type of 
inflammation observed with the CS is linked to the lipidosome activation and 
LTB4 production as well as NLRP3 inflammasome pathway leading to caspase-
1 activation [232]. ZnONW did not induce the production of IL-1β nor LTB4. 
Indication that ZnONW do not activate the inflammasome pathway. Instead 
ZnONW induce the production of IL-6 and TNF-α in a dose-dependent manner. 
Since IL-6 and TNF-α are produced after ZnONWs exposure, it appears that 
inflammation induced by ZnONWs is mediated via NF-Κβ pathway. IL-6 and 
TNF-α level were significantly reduced and after Baf-A1 and CytD treatment, 
suggesting that both the uptake and solubility of ZnONW essential for IL-6 and 
TNF-α. Moreover, exposure of BMDM to ZnONW induced the production of 
CCL11 while LKR13 cells induced both CCL11 and CCL2. The production of 
these chemokines and cytokines were consistent with our previous findings to 
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the cell types recruited in the site of exposure in lung and air-pouch mouse 
model. 
ZnONP toxicity was linked to the solubility of the particles under acidic 
conditions in the cell. However, pre-treatment of BMDMs with Baf-A1 did not 
result of IL-6 or TNF-α production upon ZnONW exposure. These results 
indicated that soluble zinc ions were mediating the production of these 
cytokines. In addition, treatment of BMDMs with ZnCl2 was not sufficient for the 
production of pro-inflammatory cytokines, suggesting that the uptake of ZnONW 
and their dissolution within the phagolysosome compartment is required for the 
activation and production of IL-6 and TNF-α. 
Studying the potential negative health implications for ZnONW exposure 
in animal models might give an insight to the possible adverse outcome for 
exposure to these particles and other ENMs that have similar properties. 
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Figure 25: Graphical summary. 
Cells take up ZnONW by phagocytosis process. During phagosome 
maturation pH drops and ZnONWs starts to dissolve. The intracellular 
dissolution leads to an increase of the Zn ion concentration and lysosomal 
destabilization, leading to toxicity and production of IL-6 and TNF-α, CCL2, 
and CCL11. Blocking the acidification of phagolysosome with Baf-A1 prevents 
the production of these cytokines. 
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FUTURE DIRECTIONS 
This dissertation studied the potential toxicity and inflammatory effects of 
ZnONW in a murine mouse model and cultured cells. Although this study 
outlines only the biological consequences for exposure to ZnONW in vivo and 
ex-vivo, it raises important issues and questions that are needs to be addressed 
and worth investigation. 
Studies presented here indicated that ZnONW induce toxicity and cell 
death to different cell lines. Toxicity of ENMs depends on both the physical and 
chemical properties. Moreover, very little is known and understood about the 
mechanisms of ENM toxicity in mammalian cells lines. The fact that ZnONW 
have sensitive dissolution points in the acidic aqueous conditions in the cells, 
and ZnO dissolution has been shown to play a role in the acute or chronic 
toxicity, the novel 1D morphology of ZnONW could lead to a different 
toxicological profile. Therefore, future studies could be aimed at understanding 
the impacts of the physical properties of ZnONW on toxicity. 
Confocal microscopy images revealed that ZnONW inside the cells were 
taken up as aggregated in presence of Baf-A1 and not as a single individual 
particle. However, we do not know whether this aggression can be reversed or 
how long these can be persisting or how they could activate an inflammatory 
cascade. Thus, mechanistic studies need to be conducted to investigate 
ZnONW’ immunomodulatory effects. 
In our previous study, crystalline silica (CS) induced sterile inflammation 
through the activation of NLRP3- inflammasome pathway and the production of 
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IL-1β and LTB4. Based on our results here, ZnONW induced sterile inflammatory 
responses in lung and air-pouch mouse models that were qualitatively and 
quantitatively distinct from CS and SiONP. ZnONW induced the recruitments of 
eosinophils and macrophages as well as the production of CCL2, CCL11 and IL-
6, and TNF-α. Previous studies with ZnONP revealed that pulmonary exposure 
to ZnONP induce the recruitment of neutrophils in lung. However, here in this 
study, ZnONW did not induce the infiltration of neutrophil in the lung; this could 
be explained by either the overwhelming cellular infiltration or that ZnONW’ 
shape elicit a different response than ZnONP. 
The cellular basis of the production of these chemokine and cytokines 
was investigated. We demonstrated the importance of LKR13 cells in the 
production of CCL11 and CCL2, with BMDMs and RAW 264.7 cells as the main 
source for IL-6 and TNF-α and its contribution to the production of CCL11. 
However, the actual sequence of the production of these chemokines and 
cytokines remains unknown. Future experiments could be aimed at 
understanding how this inflammatory pathway initiates and the molecular 
pathways involved need to be examined using inhibitors of phagocytosis and 
assessed using Western Blotting techniques. 
Lastly, this study could reveal important information about sterile 
inflammatory effects of ZnONW which could apply to similar ENMs that may 
have similar physical or chemical characteristics to ZnONW. 
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ENMs: Engineered nanomaterials 
ENPs: Engineered nanoparticles 
TiO2NP: Titanium dioxide nanoparticle 
CeO2NP: Cerium dioxide nanoparticle 
Al2O3NP: Aluminum oxide nanoparticle 
SiONP: Silicon dioxide nanoparticle 
ZnONP: Zinc oxide nanoparticle 
CNT: Carbon nanotubes 
CS: Crystalline silica 
ROS: Reactive oxygen species 
DNA: Deoxyribonucleic acid 
TWA: Time weighted average 
STEL: short-term exposure limit 
RNS: Reactive nitrogen species 
DAMP: Damage-associated molecular patterns 





TNF-α: Tumor necrosis factor alpha 
Nrf2: Nuclear factor (erythroid-derived 2)-like 2 
MAPK: Mitogen activated protein kinase 
NF-𝜅B: Nuclear factor kappa-light-chain enhancer of activated B cells 
iNOS: Inducible nitric oxide synthase 
ERKs: Extracellular signal-related kinases 
LDH: Lactate dehydrogenase 
HOCl: Hypochlorous acid 
ONOO−: Peroxynitrite 
AM: Alveolar macrophages 
HARN: High aspect ratio nanomaterials 
PARP: Poly-ADP-ribose polymerase 
TLR6: Toll-like receptor 6  
OVA: Allergen ovalbumin  
BALF: Bronchial alveolar lavage fluids  
CRP: Acute phase proteins  
SSR: Signal sequence receptor 
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PRP: Pattern recognition protein 
SR: Scavenger receptor 
MR: Mannose receptor 
CR: Complement receptor 
COPD: Chronic obstructive pulmonary diseases 
NTHi: Haemophilus influenza 
MBP: Major basic protein 
 EPO: Eosinophil peroxidase 
EDN: Eosinophil-derived neurotoxin 
H&E: Hematoxylin and eosin 
Th2: T helper 2 cells 
HMMs: Human monocyte macrophages 
H2O2: Hydrogen peroxide 
O2∙Superoxideanion 
OH∙: Hydroxylradical 
1O2: Singlet oxygen 
MCP-1: Monocyte Chemoattractant protein 1 
CCL11: Chemokine 11 or eosinophil chemotactic protein 
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BMDM: Bone marrow derived macrophage 
RAW 264.7: Macrophage-like, Abelson leukemia virus cells 
LKR13: Murine K-ras mutant lung adenocarcinoma cell line 
LPS: Lipopolysaccharide 
EE: Early endosome 
LE: Late endosome 
 Baf-A1: Bafilomycin-A1 
Cyt D: Cytocholasin D 
MTT: Methylthiazol Tetrazolium Assay 
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